<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26571023</article-id><article-id pub-id-type="pmc">4646647</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0142689</article-id><article-id pub-id-type="publisher-id">PONE-D-14-42698</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Effects of Lifestyle Modification on Telomerase Gene Expression in Hypertensive Patients: A Pilot Trial of Stress Reduction and Health Education Programs in African Americans</article-title><alt-title alt-title-type="running-head">Effects of Lifestyle Modification on Telomerase</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Duraimani</surname><given-names>Shanthi</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref><xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Schneider</surname><given-names>Robert H.</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Randall</surname><given-names>Otelio S.</given-names></name><xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Nidich</surname><given-names>Sanford I.</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Shichen</given-names></name><xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ketete</surname><given-names>Muluemebet</given-names></name><xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Rainforth</surname><given-names>Maxwell A.</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gaylord-King</surname><given-names>Carolyn</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Salerno</surname><given-names>John W.</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Fagan</surname><given-names>John</given-names></name><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref><xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib></contrib-group><aff id="aff001">
<label>1</label>
<addr-line>Center for Natural Medicine and Prevention, Maharishi University of Management Research Institute, Maharishi Vedic City, Iowa, United States of America</addr-line>
</aff><aff id="aff002">
<label>2</label>
<addr-line>Department of Physiology and Health, Maharishi University of Management, Fairfield, Iowa, United States of America</addr-line>
</aff><aff id="aff003">
<label>3</label>
<addr-line>MUM Molecular Biology Laboratory, Maharishi University of Management, Fairfield Iowa, United States of America</addr-line>
</aff><aff id="aff004">
<label>4</label>
<addr-line>Howard University College of Medicine, Department of Internal Medicine, Division of Cardiology, Washington DC, United States of America</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Eller</surname><given-names>Kathrin</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>Medical University of Graz, AUSTRIA</addr-line>
</aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have the following interests: Dr. Fagan was Chief Scientific Officer at Global ID Group, which provides commercial GMO testing services until November 2013. Since then, Dr. Fagan has no financial, professional, or personal affiliation with Global ID Group. Global ID Group provided scholarship support to Dr. Shanthi Lakshman Duraimani for her PhD studies. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.</p></fn><fn fn-type="con" id="contrib001"><p>Conceived and designed the experiments: SD JF. Performed the experiments: SD SX. Analyzed the data: SD MR. Contributed reagents/materials/analysis tools: SD JF OSR SX MK. Wrote the paper: SD RHS JF JWS SIN MAR CGK OT. Recruited subjects and collected clinical data: SD OSR SX MK.</p></fn><corresp id="cor001">* E-mail: <email>jfagan@maharishi.net</email></corresp></author-notes><pub-date pub-type="epub"><day>16</day><month>11</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>10</volume><issue>11</issue><elocation-id>e0142689</elocation-id><history><date date-type="received"><day>31</day><month>10</month><year>2014</year></date><date date-type="accepted"><day>25</day><month>10</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; 2015 Duraimani et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Duraimani et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="pone.0142689.pdf"/><abstract><sec id="sec001"><title>Background</title><p>African Americans suffer from disproportionately high rates of hypertension and cardiovascular disease. Psychosocial stress, lifestyle and telomere dysfunction contribute to the pathogenesis of hypertension and cardiovascular disease. This study evaluated effects of stress reduction and lifestyle modification on blood pressure, telomerase gene expression and lifestyle factors in African Americans.</p></sec><sec id="sec002"><title>Methods</title><p>Forty-eight African American men and women with stage I hypertension who participated in a larger randomized controlled trial volunteered for this substudy. These subjects participated in either stress reduction with the Transcendental Meditation technique and a basic health education course (SR) or an extensive health education program (EHE) for 16 weeks. Primary outcomes were telomerase gene expression (<italic>hTERT</italic> and <italic>hTR</italic>) and clinic blood pressure. Secondary outcomes included lifestyle-related factors. Data were analyzed for within-group and between-group changes.</p></sec><sec id="sec003"><title>Results</title><p>Both groups showed increases in the two measures of telomerase gene expression, <italic>hTR</italic> mRNA levels (SR: <italic>p</italic>&#x0003c; 0.001; EHE: <italic>p</italic>&#x0003c; 0.001) and <italic>hTERT</italic> mRNA levels (SR: <italic>p</italic> = 0.055; EHE: <italic>p</italic>&#x0003c; 0.002). However, no statistically significant between-group changes were observed. Both groups showed reductions in systolic BP. Adjusted changes were SR = -5.7 mm Hg, <italic>p</italic>&#x0003c; 0.01; EHE = -9.0 mm Hg, <italic>p</italic> &#x0003c; 0.001 with no statistically significant difference between group difference. There was a significant reduction in diastolic BP in the EHE group (-5.3 mm Hg, <italic>p</italic>&#x0003c; 0.001) but not in SR (-1.2 mm Hg, <italic>p</italic> = 0.42); the between-group difference was significant (<italic>p</italic> = 0.04). The EHE group showed a greater number of changes in lifestyle behaviors.</p></sec><sec id="sec004"><title>Conclusion</title><p>In this pilot trial, both stress reduction (Transcendental Meditation technique plus health education) and extensive health education groups demonstrated increased telomerase gene expression and reduced BP. The association between increased telomerase gene expression and reduced BP observed in this high-risk population suggest hypotheses that telomerase gene expression may either be a biomarker for reduced BP or a mechanism by which stress reduction and lifestyle modification reduces BP.</p></sec><sec id="sec005"><title>Trial Registration</title><p>ClinicalTrials.gov <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT00681200">NCT00681200</ext-link>
</p></sec></abstract><funding-group><funding-statement>This study was supported by grants from the National Institutes of Health-National Heart Lung and Blood Institute #HL083944; and the Howard University College of Medicine General Clinical Research Center #MO1 RR10284. Global ID Group provided scholarship support to Dr. Shanthi Lakshman Duraimani for her PhD studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Public site where parent study is described: <ext-link ext-link-type="uri" xlink:href="http://www.ClinicalTrials.gov">www.ClinicalTrials.gov</ext-link> registration #NCT00681200. None of the funders had a direct role in the design, data collection, analysis or decision to publish.</funding-statement></funding-group><counts><fig-count count="3"/><table-count count="5"/><page-count count="18"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are available from within the manuscript as well as a supplemental information file.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are available from within the manuscript as well as a supplemental information file.</p></notes></front><body><sec sec-type="intro" id="sec006"><title>Introduction</title><p>Hypertension is a major risk factor for cardiovascular disease (CVD) [<xref rid="pone.0142689.ref001" ref-type="bibr">1</xref>,<xref rid="pone.0142689.ref002" ref-type="bibr">2</xref>] There are racial/ethnic disparities in the prevalence, severity and clinical consequences of hypertension. The prevalence of hypertension is 48% higher in African Americans than white Americans [<xref rid="pone.0142689.ref003" ref-type="bibr">3</xref>]. This may contribute to the 50% higher mortality rate from cardiovascular disease in African Americans compared to whites [<xref rid="pone.0142689.ref004" ref-type="bibr">4</xref>,<xref rid="pone.0142689.ref005" ref-type="bibr">5</xref>]. There is evidence that psychosocial and environmental stress contribute to these disproportionate rates of hypertension and CVD in African Americans [<xref rid="pone.0142689.ref006" ref-type="bibr">6</xref>,<xref rid="pone.0142689.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0142689.ref008" ref-type="bibr">8</xref>].</p><p>Amongst a range of proposed mechanisms, telomere dysfunction is emerging as a potential pathophysiological mechanism for hypertension and CVD [<xref rid="pone.0142689.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0142689.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0142689.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0142689.ref012" ref-type="bibr">12</xref>]. For example, results from the Framingham Heart Study showed reduced leukocyte telomere length in individuals with a higher renin-to-aldosterone ratio, especially in patients with hypertension [<xref rid="pone.0142689.ref010" ref-type="bibr">10</xref>]. A five-year prospective study demonstrated that hypertensive patients who developed coronary artery disease (CAD) had shorter telomeres than matched patients who did not develop CAD. It proposed that telomere length is an independent risk factor for hypertension and CVD [<xref rid="pone.0142689.ref011" ref-type="bibr">11</xref>]. In an animal model, a direct link between telomerase activity and hypertension was reported. It was found that mice without telomerase displayed hypertension associated with increased in plasma endothelin ET-1 levels due to endothelin-converting enzyme ECE-1 overexpression [<xref rid="pone.0142689.ref013" ref-type="bibr">13</xref>].</p><p>In parallel, high psychosocial stress has been causally associated with low telomerase and shorter telomere length [<xref rid="pone.0142689.ref014" ref-type="bibr">14</xref>]. The mechanisms linking psychosocial stress with low telomerase levels and short telomere length may include activation of the sympathetic nervous system (SNS) and hypothalamic-pituitary-adrenal (HPA) axis, inflammation and oxidative stress [<xref rid="pone.0142689.ref014" ref-type="bibr">14</xref>,<xref rid="pone.0142689.ref015" ref-type="bibr">15</xref>]. Therefore, it may be hypothesized that psychosocial stress contributes to hypertension, at least in part, through effects on neurophysiologic mechanisms which that influence telomerase and telomere length [<xref rid="pone.0142689.ref016" ref-type="bibr">16</xref>]</p><p>Meta-analyses of randomized controlled trials of stress reduction with the Transcendental Meditation (TM) technique report reduced blood pressure in African American and white subjects [<xref rid="pone.0142689.ref017" ref-type="bibr">17</xref>,<xref rid="pone.0142689.ref018" ref-type="bibr">18</xref>,<xref rid="pone.0142689.ref019" ref-type="bibr">19</xref>]. Previous studies on the effects of stress reduction, meditation and lifestyle modifications on telomere function have been conducted in patients with prostate cancer and normal subjects [<xref rid="pone.0142689.ref020" ref-type="bibr">20</xref>]. However, to our knowledge, there has been no published study to compare effects of stress reduction and lifestyle modification for hypertension on telomere biology and blood pressure in hypertensive patients. Further, no previous study has investigated these effects in a racial/ethnic population with disparities in hypertension and CVD.</p><p>Therefore, the overall objective was to conduct a pilot study to compare effects of a stress reduction-based program to an extensive health education for hypertension on telomerase gene expression, blood pressure, lifestyle and behavioral risk factors in a sample of African American hypertensive men and women.</p></sec><sec sec-type="materials|methods" id="sec007"><title>Materials and Methods</title><sec id="sec008"><title>Design</title><p>This study was part of a larger randomized controlled trial on physiological mechanisms of stress reduction and lifestyle modification for hypertension in African Americans. In the parent trial, 152 African American men and women with stage I hypertension were randomly assigned to a Transcendental Meditation-based program plus health education program (stress reduction, SR) or an extensive health education (EHE) program. As shown in the patient flow diagram (<xref rid="pone.0142689.g001" ref-type="fig">Fig 1</xref>), 48 of the 152 original randomized subjects (24 per group) volunteered for this ancillary study. All subjects were tested at baseline and after four months. Primary outcomes were expression of the telomerase genes: <italic>hTR</italic>, <italic>hTERT</italic> and clinic blood pressure. Secondary outcomes were psychosocial stress factors, dietary intake, body mass index, physical activity and telomere length.</p><fig id="pone.0142689.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0142689.g001</object-id><label>Fig 1</label><caption><title>Participant Flow Diagram.</title></caption><graphic xlink:href="pone.0142689.g001"/></fig><p>The clinical site was Howard University Medical Center, Washington, DC. The study coordinating center was Maharishi University of Management Research Institute (MUMRI) in Maharishi Vedic City, Iowa. The institutional review boards of Howard University and Maharishi University of Management reviewed and approved the protocols in December 2007, December 2009, and April 2010. Subjects provided written informed consent twice. The first consent was for participation in the parent trial and the second consent was for participation in the telomere biology substudy study. Randomization of subjects into the study arms began in April 2008; data collection was completed in March 2012. There was a brief administrative delay for registration on ClinicalTrials.gov which occurred in May 2008. The overall trial was monitored by an independent data and safety monitoring board.</p></sec><sec id="sec009"><title>Participants</title><p>Eligibility criteria included: age &#x02265; 40 years, male or female, stage I hypertension (SBP 140&#x02013;159 mm Hg and /or DBP 90&#x02013;99 mm Hg). Subjects who were taking two or more antihypertensive medications or sympatholytic medications i.e., beta blocker, alpha blocker, central adrenergic agent, ACE inhibitor were excluded. (The rationale for excluding subjects who required sympatholytics was that these classes of medications might have interfered with measures of sympathetic nervous system functioning used in the assessment battery for the parent study.) Subjects who had a history of major psychiatric disorders, dementia or substance abuse disorder, or any life threatening illness were excluded.</p></sec><sec id="sec010"><title>Procedure</title><p>Subjects were recruited from Howard University Hospital clinics and through local media. Potential subjects who had a history of stage I hypertension but who were taking excluded antihypertensive medications were offered the opportunity to taper off these medications to determine if they were eligible according to BP criteria.</p><p>After baseline measurements in the parent trial, subjects were randomly allocated to the SR or EHE programs with stratification for antihypertensive medication status. There were three strata: no medication, diuretic only, or non-diuretic antihypertensive medication. Randomization was performed by the study biostatistician using computer generated random sequence. The study biostatistician concealed the allocation schedule and conveyed the assignments to the study coordinator. Investigators, data collectors and data management staff were blinded to group assignment. Intervention groups met separately to minimize contamination. This was a single blind protocol recommended for behavioral intervention trials [<xref rid="pone.0142689.ref021" ref-type="bibr">21</xref>]. Subjects were assessed at baseline and monthly for blood pressure (BP) and at baseline and four months for telomerase gene expression, body mass index (BMI), lifestyle behaviors (diet, physical activity and substance use), psychosocial distress factors, telomere length, and intervention adherence.</p></sec><sec id="sec011"><title>Outcomes</title><sec id="sec012"><title>Blood Pressure</title><p>Resting clinic blood pressure was measured in a standardized protocol by trained and certified observers using a Dinamap DPC 120X automated BP device (GE Medical Information Technologies, Chicago, IL). BP was measured three times at one-minute intervals in the seated position [<xref rid="pone.0142689.ref022" ref-type="bibr">22</xref>]. The first reading was discarded and the last two readings were averaged. BP was assessed at baseline and every month during the four-month follow up period.</p></sec><sec id="sec013"><title>Venipuncture</title><p>Venipuncture blood draws of 20 mL per subject at baseline and at posttest were taken by a trained phlebotomist at the Howard University General Research Center (GRC). Blood was collected in red labeled serum tubes without additives and frozen at -70&#x000b0; C on site. When all blood data was collected, frozen blood tubes were shipped on dry ice from Howard University in Washington, DC to the MUM Molecular Biology Laboratory in Fairfield, Iowa.</p></sec><sec id="sec014"><title>RNA Extraction</title><p>A total of 96 frozen blood clot samples (50&#x02013;100 mg) were lysed in vials with 1mL of TRIZOL reagent (Ambion, AM9738). Homogenization was performed using a mortar and pestle, which was thoroughly washed first with RNAase ZAP solution (Ambion, AM9780), and then with DEPC treated water (Ambion, 4387937). The samples were then incubated at room temperature for 5&#x02013;10 min. The homogenate was centrifuged at 12,000 g for 15 min at 4&#x000b0;C and the supernatant transferred to a new micro centrifuge tube. Next, 0.2 mL chloroform was added to the supernatant and after thorough vortexing, incubated at room temperature for 5&#x02013;15 min. After centrifugation at 12,000 g for 15 min at 4&#x000b0;C, the upper aqueous phase was carefully removed, and transferred to new vials.</p><p>The RNA was precipitated with 0.5 mL isopropyl alcohol per 1mL of TRIZOL reagent and incubated at room temperature for 10 min. After centrifugation at 12,000 g for 8 min at 4&#x000b0;C the pellet was washed 2 times with 1 mL of 75% ethanol. The RNA pellet was dried at room temperature and re-suspended in 80 &#x003bc;L of the RNA storage solution (Ambion, AM7001).</p><p>In order to remove DNA, 50 &#x003bc;L of RNA sample was treated with 5&#x003bc;L 10x turbo reaction buffer and incubated at 37&#x000b0;C for 30 min. 5 &#x003bc;L of the DNase inactivation reagent were added and centrifuged at 10,000 x g for 3 min. 40 &#x003bc;L were removed and used for further analysis.</p><p>The purity of RNA was assessed by comparing light absorption at 260 nm versus 280 nm, and the integrity of RNA was verified by electrophoresis in 1% agarose gels, staining with ethidium bromide, and observation of well-defined 28S and 18S rRNA bands using the Gel Doc 1000/2000 image analysis system (BioRad, CA, USA).</p></sec><sec id="sec015"><title>Telomerase Gene Expression&#x02014;hTR and hTERT mRNA Quantification by RT PCR</title><p>Telomerase is an RNA-dependent DNA polymerase that synthesizes telomeric DNA sequences. Activity of this enzyme is recognized almost universally as contributing to cellular proliferative potential [<xref rid="pone.0142689.ref023" ref-type="bibr">23</xref>]. Telomerase consists of two essential components: one is the functional RNA component (in humans called <italic>hTR</italic>), which serves as a template for telomeric DNA synthesis; the other is a catalytic protein (<italic>hTERT</italic>) with reverse transcriptase activity. Cells with elevated telomerase activity show delayed senescence and cellular aging [<xref rid="pone.0142689.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0142689.ref023" ref-type="bibr">23</xref>].</p><p>Telomerase gene expression (<italic>hTR</italic>, <italic>hTERT</italic>) was determined by measurement of the levels of <italic>hTR</italic> and <italic>hTERT</italic> mRNA by the quantitative real time reverse transcriptase polymerase chain reaction (RT-PCR) (using the ABI Biosystem 7500 real-time PCR system. Analysis was carried out according to Yajima T <italic>et al</italic>.[<xref rid="pone.0142689.ref024" ref-type="bibr">24</xref>] with modifications of the <italic>GAPDH</italic> forward primer and the <italic>hTERT</italic> reverse primers (<ext-link ext-link-type="uri" xlink:href="http://frodo.wi.mit.edu/primer3/">http://frodo.wi.mit.edu/primer3/</ext-link>) in order to obtain shorter PCR products.</p><p>Primers were synthesized by Integrated DNA Technologies, USA. PCR reactions (25&#x003bc;L) contained 12.5&#x003bc;L of 2x Quantifast RT PCR Mix (Qiagen multiplex Quantifast, 204954), 0.5 &#x003bc;L of 50x ROX dye solution, 1.25 &#x003bc;L of 20x primer-probe mix, 0.25&#x003bc;L of reverse transcriptase (RT) mix (QIAGEN OneStep RT-PCR Enzyme Mix), 0.5&#x003bc;L of RNase free water, 10 &#x003bc;L of template RNA or universal RNA (50 ng). The thermal cycling profile consisted of 20 min reverse transcription at 50&#x000b0;C, 5 min PCR initial activation step, at 95&#x000b0;C; 15 sec denaturation at 95&#x000b0;C, 15 sec annealing/extension at 60&#x000b0;C. Forty cycles of denaturation and annealing/extension were carried out.</p><p>To normalize for differences in the amount of total RNA added to each reaction, relative quantification of the <italic>hTERT</italic> and <italic>hTR</italic> mRNAs was carried out, using as internal reference amplification of the endogenous <italic>GAPDH</italic> mRNA. Nuclease free water was used as negative control, and universal RNA (Amsbio, R1234148-10) was used as positive control. Relative quantification measures the levels of the target gene mRNAs (<italic>hTR and hTERT</italic>) relative to the level of <italic>GAPDH</italic> mRNA.</p></sec><sec id="sec016"><title>Telomere Length Determination</title><p>An exploratory analysis of telomere length change was performed using the Bio-Rad MyiQ Single Color Real-Time PCR Detection System. Telomere primer pair telg and telc and scg albumin primers were synthesized by Integrated DNA technologies, USA (<xref rid="pone.0142689.t001" ref-type="table">Table 1</xref>). The final concentrations of the telomere primer pair telg and telc, and scg albumin primer pair was 900 nM each in the master mix. PCR reactions were set up by aliquoting 12.5&#x003bc;L of QuantiFast SYBR Green master mix (Qiagen, 204057) and DNA sample (10&#x003bc;L), containing approximately 50ng of DNA diluted in pure water, for a final volume of 25&#x003bc;L per reaction. Three concentrations of reference DNA sample (Standard DNA) spanning an 81-fold range of DNA concentration were prepared in duplicate in every 96-well plate in this study. These reactions provided the data for the generation of the standard curves used for relative quantification. Inter and intra assay variability was adequate. DNA from all subjects, were run in duplicate.</p><table-wrap id="pone.0142689.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0142689.t001</object-id><label>Table 1</label><caption><title>Primer and probe sequences.</title></caption><alternatives><graphic id="pone.0142689.t001g" xlink:href="pone.0142689.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><tbody><tr><td align="left" rowspan="1" colspan="1">
<italic>hTR</italic> forward primer</td><td align="left" rowspan="1" colspan="1">FW: 5'-GGTGGTGGCCATTTTTTGTC-3'</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>hTR</italic> Reverse Primer</td><td align="left" rowspan="1" colspan="1">RV: 5'-CTAGAATGAACGGTGGAAGGC-3'</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>hTR</italic> Probe</td><td align="left" rowspan="1" colspan="1">probe 5'-FAM CGCGCTGTTTTTCTCGCTGACTTTC-3'</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>hTERT</italic> Forward Primer</td><td align="left" rowspan="1" colspan="1">FW: 5' -ACGGCGACATGGAGAACA A-3'</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>hTERT</italic> Reverse Primer</td><td align="left" rowspan="1" colspan="1">RV: 5'-GGGTCCTGAGGAAGGTTTTC-3'</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>hTERT</italic> Probe</td><td align="left" rowspan="1" colspan="1">probe: 5'-6-FAM-CTCCTGCGTTGGTGGATGATTTCTTGTTG-3'</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>GAPDH</italic> forward primer</td><td align="left" rowspan="1" colspan="1">FW: 5'-CAATGACCCCTTCATTGACC-3'</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>GAPDH</italic> reverse primer</td><td align="left" rowspan="1" colspan="1">RV: 5'-GAAGATGGTGATGGGATTTC-3'</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>GAPDH</italic> probe</td><td align="left" rowspan="1" colspan="1">probe 5'-Cy5-CAAGCTTCCCGTTCTCAGCC- 3'</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>
<italic>hTR</italic>- Human Telomerase RNA Subunit; <italic>hTERT</italic>-human telomerase reverse transcriptase; GAPDH- glyceraldehydes 3-phosphate dehydrogenase</p></fn></table-wrap-foot></table-wrap><p>The thermal cycling profile consisted of Stage 1: 15 min at 95&#x000b0;C; Stage 2: 2 cycles of 15 sec at 94&#x000b0;C, 15 sec at 49&#x000b0;C; and Stage 3: 32 cycles of 15 sec at 94&#x000b0;C, 10 sec at 62&#x000b0;C, 15 sec at 74&#x000b0;C with signal acquisition, 10 sec at 84&#x000b0;C, 15 s at 88&#x000b0;C with signal acquisition. The 74&#x000b0;C reads provided the Ct values for the amplification of the telomere template (in early cycles when the scg signal is still at baseline); the 88&#x000b0;C reads provided the Ct values for the amplification of the scg template (at this temperature there is no signal from the telomere PCR product, because it is fully melted). Relative mean telomere length, or T/S ratio, was measured according to the protocol of Cawthon [<xref rid="pone.0142689.ref025" ref-type="bibr">25</xref>]. Relative T/S ratios reflect relative length differences in telomeric DNA only if the number of copies of S per cell that are effectively PCR-amplified is the same in all individuals being studied.</p></sec><sec id="sec017"><title>Behavioral and Lifestyle factors</title><p>BMI was calculated as weight/height<sup>2</sup>. Dietary patterns were assessed with the Block Dietary Food Consumption Questionnaire [<xref rid="pone.0142689.ref026" ref-type="bibr">26</xref>]. The Anger Expression (AX) scale was used to assess anger-in, anger-out, anger-control and total anger [<xref rid="pone.0142689.ref027" ref-type="bibr">27</xref>]. A modified Minnesota leisure time physical activity questionnaire was used for exercise [<xref rid="pone.0142689.ref028" ref-type="bibr">28</xref>].</p></sec></sec><sec id="sec018"><title>Interventions</title><p>The two interventions were matched for time, attention and other nonspecific factors. The stress reduction (SR) methods were the Transcendental Meditation (TM) technique. The TM technique was chosen as the stress reduction intervention for this study because of its standardization, reproducibility and previously demonstrated effects on physiological correlates of stress [<xref rid="pone.0142689.ref029" ref-type="bibr">29</xref>,<xref rid="pone.0142689.ref030" ref-type="bibr">30</xref>,<xref rid="pone.0142689.ref031" ref-type="bibr">31</xref>]. The TM technique is described as a simple, natural and effortless procedure that is practiced for 20 minutes twice a day while sitting with closed eyes [<xref rid="pone.0142689.ref030" ref-type="bibr">30</xref>,<xref rid="pone.0142689.ref032" ref-type="bibr">32</xref>,<xref rid="pone.0142689.ref033" ref-type="bibr">33</xref>]. During the practice, it has been reported that ordinary thinking processes settle down and a distinctive wakeful hypometabolic state characterized by neural coherence and physiological rest is achieved [<xref rid="pone.0142689.ref029" ref-type="bibr">29</xref>,<xref rid="pone.0142689.ref033" ref-type="bibr">33</xref>,<xref rid="pone.0142689.ref034" ref-type="bibr">34</xref>]. The teachers were African American and certified by Maharishi Foundation USA. Standard teaching materials and format were used. The instruction involved a standardized seven-step course comprising six 1.5&#x02013;2 hour individual and group meetings over six days [<xref rid="pone.0142689.ref030" ref-type="bibr">30</xref>,<xref rid="pone.0142689.ref032" ref-type="bibr">32</xref>]. Follow up meetings were held twice a month for approximately one hour each for the duration of the 16 week intervention period (16 hours of stress reduction instruction and follow up). In addition, the stress reduction group received basic health education for hypertension recommended by the Seventh Joint National Commission on Detection, Evaluation and Treatment of High Blood Pressure (JNC VII) [<xref rid="pone.0142689.ref035" ref-type="bibr">35</xref>]. This supplementary class comprised eight sessions of one hour each, conducted every other week during the 16 week intervention period. The basic health education classes for the SR group were primarily didactic in format requiring no home practice, social support or other motivational reinforcements. Total intervention time for the SR group was 24 hours over 16 weeks.</p><p>The extensive health education (EHE) intervention actively taught JNC VII recommendations for lifestyle modification for hypertension [<xref rid="pone.0142689.ref035" ref-type="bibr">35</xref>]. The lifestyle modifications included weight reduction, dietary sodium restriction, and adoption of a Dietary Approaches to Stop Hypertension (DASH) type eating plan, regular physical activity and moderation in alcohol consumption [<xref rid="pone.0142689.ref036" ref-type="bibr">36</xref>]. The EHE group received additional substantial active reinforcement for lifestyle change through motivational videos, field trips and social support groups. The intervention comprised eight one-hour meetings and eight two-hour sessions during the course of the study. Subjects were encouraged to modify hypertension-related health behaviors in their daily lives. There was no stress reduction technique taught in the EHE intervention. Total intervention time for the EHE group was 24 hours over 16 weeks.</p></sec><sec id="sec019"><title>Data Analysis</title><p>Baseline characteristics were compared with <italic>t</italic> tests for independent variables. Outcome data were assessed for within-group and between-group differences. Normality of distribution was tested by skewness and kurtosis. Normally distributed outcome data were tested for within-group differences by dependent <italic>t</italic> test and for between-group differences by analysis of covariance (ANCOVA) using baseline level as a covariate as well as variables on which there were significant baseline differences between the groups. Non-normally distributed data were tested for within-group differences by Wilcoxon matched pair test and for between-group differences by Kruskal Wallis ANOVA test. Statistical analyses were performed using SPSS software, Windows version 14.0 (IBM SPSS, Armonk, NY). All tests were two-tailed. Analyses were conducted according to the intention-to-treat principle.</p></sec></sec><sec sec-type="results" id="sec020"><title>Results</title><p>The baseline characteristics of each group are shown in <xref rid="pone.0142689.t002" ref-type="table">Table 2</xref>.</p><table-wrap id="pone.0142689.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0142689.t002</object-id><label>Table 2</label><caption><title>Baseline Characteristics.</title></caption><alternatives><graphic id="pone.0142689.t002g" xlink:href="pone.0142689.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Parameters</th><th align="center" rowspan="1" colspan="1">SR groupMean &#x000b1; SD</th><th align="center" rowspan="1" colspan="1">EHE groupMean &#x000b1; SD</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">60.4&#x000b1;11.9</td><td align="center" rowspan="1" colspan="1">55.7&#x000b1;8.83</td></tr><tr><td align="center" rowspan="1" colspan="1">Gender (male)</td><td align="center" rowspan="1" colspan="1">45.8%</td><td align="center" rowspan="1" colspan="1">45.8%</td></tr><tr><td align="center" rowspan="1" colspan="1">Weight, kg</td><td align="center" rowspan="1" colspan="1">86.0 &#x000b1; 15.5</td><td align="center" rowspan="1" colspan="1">89.4 &#x000b1; 16.0</td></tr><tr><td align="center" rowspan="1" colspan="1">BMI, kg/m<sup>2</sup>
</td><td align="center" rowspan="1" colspan="1">30.5 &#x000b1; 4.5</td><td align="center" rowspan="1" colspan="1">30.7 &#x000b1; 5.7</td></tr><tr><td align="center" rowspan="1" colspan="1">SBP, mm Hg</td><td align="center" rowspan="1" colspan="1">144.8 &#x000b1; 4.2</td><td align="center" rowspan="1" colspan="1">146.7 &#x000b1; 5.5</td></tr><tr><td align="center" rowspan="1" colspan="1">DBP, mm Hg</td><td align="center" rowspan="1" colspan="1">83.0 &#x000b1; 1.4</td><td align="center" rowspan="1" colspan="1">87.5 &#x000b1; 1.5</td></tr><tr><td align="center" rowspan="1" colspan="1">
<italic>hTERT</italic>
</td><td align="center" rowspan="1" colspan="1">1.23+2.76</td><td align="center" rowspan="1" colspan="1">0.81+1.25</td></tr><tr><td align="center" rowspan="1" colspan="1">
<italic>hTR</italic>
</td><td align="center" rowspan="1" colspan="1">1.50+1.81</td><td align="center" rowspan="1" colspan="1">4.21+6.00</td></tr><tr><td align="center" rowspan="1" colspan="1">Anger-in (-, 0&#x02013;24)</td><td align="center" rowspan="1" colspan="1">5.7&#x000b1;4.2</td><td align="center" rowspan="1" colspan="1">6.1&#x000b1;4.0</td></tr><tr><td align="center" rowspan="1" colspan="1">Anger-out (-, 0&#x02013;24)</td><td align="center" rowspan="1" colspan="1">6.9&#x000b1;3.0</td><td align="center" rowspan="1" colspan="1">6.1&#x000b1;1.9</td></tr><tr><td align="center" rowspan="1" colspan="1">Anger control (+,0&#x02013;24)</td><td align="center" rowspan="1" colspan="1">14.2&#x000b1;3.5</td><td align="center" rowspan="1" colspan="1">13.1&#x000b1;2.8</td></tr><tr><td align="center" rowspan="1" colspan="1">Anger total (-,0&#x02013;72)</td><td align="center" rowspan="1" colspan="1">22.3&#x000b1;7.4</td><td align="center" rowspan="1" colspan="1">24.3&#x000b1;7.7</td></tr><tr><td align="center" rowspan="1" colspan="1">Moderate activity (min/wk)</td><td align="center" rowspan="1" colspan="1">157.5&#x000b1;169.0</td><td align="center" rowspan="1" colspan="1">77.70&#x000b1;69.6</td></tr><tr><td align="center" rowspan="1" colspan="1">Vigorous activity (min/wk)</td><td align="center" rowspan="1" colspan="1">77.0&#x000b1;103.9</td><td align="center" rowspan="1" colspan="1">33.7&#x000b1;51.6</td></tr><tr><td align="center" rowspan="1" colspan="1">Carbohydrate (g)</td><td align="center" rowspan="1" colspan="1">233.1&#x000b1;136.9</td><td align="center" rowspan="1" colspan="1">174.9&#x000b1;67.8</td></tr><tr><td align="center" rowspan="1" colspan="1">Protein (g)</td><td align="center" rowspan="1" colspan="1">77.7&#x000b1;46.1</td><td align="center" rowspan="1" colspan="1">48.5&#x000b1;21.3</td></tr><tr><td align="center" rowspan="1" colspan="1">Fiber (g)</td><td align="center" rowspan="1" colspan="1">19.5&#x000b1;8.5</td><td align="center" rowspan="1" colspan="1">12.24&#x000b1;5.1</td></tr><tr><td align="center" rowspan="1" colspan="1">Sodium (mg)</td><td align="center" rowspan="1" colspan="1">2624.9&#x000b1;1459.5</td><td align="center" rowspan="1" colspan="1">1737.7&#x000b1;671.2</td></tr><tr><td align="center" rowspan="1" colspan="1">Total Calorie</td><td align="center" rowspan="1" colspan="1">1971.3&#x000b1;1383.8</td><td align="center" rowspan="1" colspan="1">1470.3&#x000b1;537.0</td></tr><tr><td align="center" rowspan="1" colspan="1">Total Fat (g)</td><td align="center" rowspan="1" colspan="1">93.2&#x000b1;66.4</td><td align="center" rowspan="1" colspan="1">60.6&#x000b1;23.0</td></tr><tr><td align="center" rowspan="1" colspan="1">Linoleic acid (g)</td><td align="center" rowspan="1" colspan="1">19.2&#x000b1;12.4</td><td align="center" rowspan="1" colspan="1">12.9&#x000b1;3.9</td></tr><tr><td align="center" rowspan="1" colspan="1">Oleic acid (g)</td><td align="center" rowspan="1" colspan="1">35.1&#x000b1;25.5</td><td align="center" rowspan="1" colspan="1">23.4&#x000b1;9.4</td></tr><tr><td align="center" rowspan="1" colspan="1">No Anti Hypertensive Medication</td><td align="center" rowspan="1" colspan="1">0.4&#x000b1;0.5</td><td align="center" rowspan="1" colspan="1">0.5 &#x000b1;0.5</td></tr><tr><td align="center" rowspan="1" colspan="1">Diuretics only</td><td align="center" rowspan="1" colspan="1">0.2&#x000b1;0.4</td><td align="center" rowspan="1" colspan="1">0.3&#x000b1;0.5</td></tr><tr><td align="center" rowspan="1" colspan="1">ACE&#x02014;Inhibitors</td><td align="center" rowspan="1" colspan="1">0.2&#x000b1;0.4</td><td align="center" rowspan="1" colspan="1">0.3&#x000b1;0.5</td></tr><tr><td align="center" rowspan="1" colspan="1">Angiotensin receptor antagonist</td><td align="center" rowspan="1" colspan="1">0.3&#x000b1;0.5</td><td align="center" rowspan="1" colspan="1">0.1&#x000b1;0.4</td></tr><tr><td align="center" rowspan="1" colspan="1">Beta blocker</td><td align="center" rowspan="1" colspan="1">0.04&#x000b1;0.2</td><td align="center" rowspan="1" colspan="1">0.2&#x000b1;0.4</td></tr><tr><td align="center" rowspan="1" colspan="1">Other antihypertensive medication</td><td align="center" rowspan="1" colspan="1">0.6&#x000b1;0.5</td><td align="center" rowspan="1" colspan="1">0.6&#x000b1;0.5</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); SBP, systolic blood pressure; DBP, diastolic blood pressure; SR, stress reduction program; EHE, extensive health education group.</p></fn></table-wrap-foot></table-wrap><p>The groups were generally well matched; however, there were significant baseline differences in diastolic BP. When the baseline characteristics of the 48 subjects in this substudy were compared to the 104 subjects in the parent study, the results were generally similar except that the substudy group had a greater percentage of males (47.9% vs. 27.9%, p = .02) and a lower average BMI (30.0 vs. 32.4, p = .03) (data in <xref rid="pone.0142689.s003" ref-type="supplementary-material">S1 Table</xref>).</p><p>The telomerase gene expression results showed significant within-group changes in both the SR and EHE groups (<xref rid="pone.0142689.t003" ref-type="table">Table 3</xref>) (Figs <xref rid="pone.0142689.g002" ref-type="fig">2</xref> and <xref rid="pone.0142689.g003" ref-type="fig">3</xref>).</p><fig id="pone.0142689.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0142689.g002</object-id><label>Fig 2</label><caption><title>Pre-post changes in telomerase component (HTR) gene expression in the Stress Reduction (SR) and Extensive Health Education (EHE) groups.</title></caption><graphic xlink:href="pone.0142689.g002"/></fig><fig id="pone.0142689.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0142689.g003</object-id><label>Fig 3</label><caption><title>Pre-post changes in telomerase component (HTERT) gene expression in the Stress Reduction (SR) and Extensive Health Education (EHE) groups.</title></caption><graphic xlink:href="pone.0142689.g003"/></fig><table-wrap id="pone.0142689.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0142689.t003</object-id><label>Table 3</label><caption><title>Changes in Telomerase Gene Expression.</title></caption><alternatives><graphic id="pone.0142689.t003g" xlink:href="pone.0142689.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">SR group</th><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">EHE group</th><th align="left" rowspan="1" colspan="1"/></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Median</th><th align="left" rowspan="1" colspan="1">Inter-quartile range</th><th align="left" rowspan="1" colspan="1">Within group significance p value</th><th align="left" rowspan="1" colspan="1">Median</th><th align="left" rowspan="1" colspan="1">Inter-quartile range</th><th align="left" rowspan="1" colspan="1">Within group significance p value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">hTR</td><td align="left" rowspan="1" colspan="1">0.285</td><td align="left" rowspan="1" colspan="1">10.872</td><td align="left" rowspan="1" colspan="1">&#x0003c; 0.001</td><td align="left" rowspan="1" colspan="1">5.4</td><td align="left" rowspan="1" colspan="1">22.827</td><td align="left" rowspan="1" colspan="1">&#x0003c; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">hTERT</td><td align="left" rowspan="1" colspan="1">0.035</td><td align="left" rowspan="1" colspan="1">1.576</td><td align="left" rowspan="1" colspan="1">0.055</td><td align="left" rowspan="1" colspan="1">0.600</td><td align="left" rowspan="1" colspan="1">4.325</td><td align="left" rowspan="1" colspan="1">0.002</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>Within group effects are calculated using Wilcoxon matched pair test; between group effects are calculated using Kruskal-Wallis ANOVA Test</p></fn></table-wrap-foot></table-wrap><p>The functional RNA component of telomerase, <italic>hTR</italic>, increased in both groups (<italic>p</italic> &#x0003c; .001 for SR and <italic>p</italic> &#x0003c; .001 for EHE). The catalytic component of telomerase, <italic>hTERT</italic>, increased in both the SR group (<italic>p</italic> = 0.055) and the EHE group (<italic>p</italic> = 0.002). There were no significant differences between the groups in <italic>hTERT</italic> or <italic>hTR</italic> gene expression.</p><p>As shown in <xref rid="pone.0142689.t004" ref-type="table">Table 4</xref>, both groups showed significant within-group reductions in systolic BP. The adjusted changes were: SR = -5.7 mm Hg, <italic>p</italic> &#x0003c; 0.01; EHE = -9.0 mm Hg, <italic>p</italic>&#x0003c; 0.001).</p><table-wrap id="pone.0142689.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0142689.t004</object-id><label>Table 4</label><caption><title>Changes in Blood Pressure.</title></caption><alternatives><graphic id="pone.0142689.t004g" xlink:href="pone.0142689.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Parameters</th><th align="center" rowspan="1" colspan="1">SR (mean &#x000b1; SD)</th><th align="center" rowspan="1" colspan="1">Within group significance <italic>p</italic> value</th><th align="center" rowspan="1" colspan="1">EHE (mean &#x000b1; SD)</th><th align="center" rowspan="1" colspan="1">Within group significance <italic>p</italic> value</th><th align="center" rowspan="1" colspan="1">Between group significance <italic>p</italic> value</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">SBP, mm Hg Unadjusted</td><td align="center" rowspan="1" colspan="1">-5.6 &#x000b1;9.6</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.01</td><td align="center" rowspan="1" colspan="1">-10.0 &#x000b1;10.9</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1">DBP, mm Hg Unadjusted</td><td align="center" rowspan="1" colspan="1">-0.9 &#x000b1;5.4</td><td align="center" rowspan="1" colspan="1">0.42</td><td align="center" rowspan="1" colspan="1">-5.6 &#x000b1;7.1</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1">SBP, mm Hg Adjusted</td><td align="center" rowspan="1" colspan="1">-5.7 &#x000b1; 10.8</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-9.0 &#x000b1;10.8</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.20</td></tr><tr><td align="center" rowspan="1" colspan="1">DBP, mm Hg Adjusted</td><td align="center" rowspan="1" colspan="1">-1.2 &#x000b1; 6.4</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-5.3 &#x000b1;6.4</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.04</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p>SD-Standard Deviation</p></fn></table-wrap-foot></table-wrap><p>There was no significant difference between groups in systolic BP reduction. For diastolic BP, the adjusted changes were: SR = -1.2 mm Hg, <italic>p</italic> = 0.42; EHE = -5.3 mm Hg, <italic>p</italic> &#x0003c;0.001). The between-group difference in diastolic BP change was significant (<italic>p</italic> = 0.04). A sensitivity analysis that included baseline age and physical activity in an ANCOVA yielded essentially the same results as the ANCOVA above with baseline BP as the covariate.</p><p>
<xref rid="pone.0142689.t005" ref-type="table">Table 5</xref> shows changes in lifestyle-related factors.</p><table-wrap id="pone.0142689.t005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0142689.t005</object-id><label>Table 5</label><caption><title>Secondary Outcome Changes.</title></caption><alternatives><graphic id="pone.0142689.t005g" xlink:href="pone.0142689.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Parameters</th><th align="center" rowspan="1" colspan="1">SR (Change mean score &#x000b1;SD)</th><th align="center" rowspan="1" colspan="1">Within group significance<italic>p</italic> value</th><th align="center" rowspan="1" colspan="1">EHE (Change mean score &#x000b1;SD)</th><th align="center" rowspan="1" colspan="1">Within group significance<italic>p</italic> value</th><th align="center" rowspan="1" colspan="1">Between group significance<italic>p</italic> value<sup>&#x02020;</sup>
</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">Weight, kg</td><td align="center" rowspan="1" colspan="1">-0.5 &#x000b1;3.1</td><td align="center" rowspan="1" colspan="1">0.48</td><td align="center" rowspan="1" colspan="1">0.2 &#x000b1;3.1</td><td align="center" rowspan="1" colspan="1">0.73</td><td align="center" rowspan="1" colspan="1">0.39</td></tr><tr><td align="center" rowspan="1" colspan="1">BMI, kg/m<sup>2</sup>
</td><td align="center" rowspan="1" colspan="1">0.04 &#x000b1;4.05</td><td align="center" rowspan="1" colspan="1">0.96</td><td align="center" rowspan="1" colspan="1">0.71 &#x000b1;2.46</td><td align="center" rowspan="1" colspan="1">0.18</td><td align="center" rowspan="1" colspan="1">0.61</td></tr><tr><td align="center" rowspan="1" colspan="1">Anger-in (-, 0&#x02013;24)</td><td align="center" rowspan="1" colspan="1">-1.0 &#x000b1;3.3</td><td align="center" rowspan="1" colspan="1">0.17</td><td align="center" rowspan="1" colspan="1">-0.2 &#x000b1;4.1</td><td align="center" rowspan="1" colspan="1">0.81</td><td align="center" rowspan="1" colspan="1">0.15</td></tr><tr><td align="center" rowspan="1" colspan="1">Anger-out (-, 0&#x02013;24)</td><td align="center" rowspan="1" colspan="1">-1.0 &#x000b1;2.5</td><td align="center" rowspan="1" colspan="1">0.09</td><td align="center" rowspan="1" colspan="1">-0.4 &#x000b1;2.6</td><td align="center" rowspan="1" colspan="1">0.49</td><td align="center" rowspan="1" colspan="1">0.62</td></tr><tr><td align="center" rowspan="1" colspan="1">Anger control (+, 0&#x02013;24)</td><td align="center" rowspan="1" colspan="1">-0.9 &#x000b1;3.7</td><td align="center" rowspan="1" colspan="1">0.29</td><td align="center" rowspan="1" colspan="1">1.1 &#x000b1;3.4</td><td align="center" rowspan="1" colspan="1">0.13</td><td align="center" rowspan="1" colspan="1">0.46</td></tr><tr><td align="center" rowspan="1" colspan="1">Anger total (-, 0&#x02013;72)</td><td align="center" rowspan="1" colspan="1">-1.1 &#x000b1;4.0</td><td align="center" rowspan="1" colspan="1">0.21</td><td align="center" rowspan="1" colspan="1">-1.7 &#x000b1;7.6</td><td align="center" rowspan="1" colspan="1">0.29</td><td align="center" rowspan="1" colspan="1">0.64</td></tr><tr><td align="center" rowspan="1" colspan="1">Moderate activity (min/wk)</td><td align="center" rowspan="1" colspan="1">-31.7 &#x000b1;118.3</td><td align="center" rowspan="1" colspan="1">0.27</td><td align="center" rowspan="1" colspan="1">-31.3 &#x000b1;102.1</td><td align="center" rowspan="1" colspan="1">0.20</td><td align="center" rowspan="1" colspan="1">0.11</td></tr><tr><td align="center" rowspan="1" colspan="1">Vigorous activity (min/wk)</td><td align="center" rowspan="1" colspan="1">-25.0 &#x000b1;86.9</td><td align="center" rowspan="1" colspan="1">0.24</td><td align="center" rowspan="1" colspan="1">-1.1 &#x000b1;87.3</td><td align="center" rowspan="1" colspan="1">0.96</td><td align="center" rowspan="1" colspan="1">0.86</td></tr><tr><td align="center" rowspan="1" colspan="1">Sodium (mg)</td><td align="center" rowspan="1" colspan="1">-618.1 &#x000b1;862.6</td><td align="center" rowspan="1" colspan="1">0.02</td><td align="center" rowspan="1" colspan="1">-343.4 &#x000b1;421.0</td><td align="center" rowspan="1" colspan="1">0.02</td><td align="center" rowspan="1" colspan="1">0.62</td></tr><tr><td align="center" rowspan="1" colspan="1">Carbohydrate (g)</td><td align="center" rowspan="1" colspan="1">-50.4 &#x000b1;106.0</td><td align="center" rowspan="1" colspan="1">0.10</td><td align="center" rowspan="1" colspan="1">-49.7 &#x000b1;40.4</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.01</td><td align="center" rowspan="1" colspan="1">0.64</td></tr><tr><td align="center" rowspan="1" colspan="1">Protein (g)</td><td align="center" rowspan="1" colspan="1">-13.9 &#x000b1;20.8</td><td align="center" rowspan="1" colspan="1">0.03</td><td align="center" rowspan="1" colspan="1">-12.3 &#x000b1;10.5</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.01</td><td align="center" rowspan="1" colspan="1">0.70</td></tr><tr><td align="center" rowspan="1" colspan="1">Fiber (g)</td><td align="center" rowspan="1" colspan="1">-2.4 &#x000b1;7.3</td><td align="center" rowspan="1" colspan="1">0.24</td><td align="center" rowspan="1" colspan="1">-1.3 &#x000b1;4.0</td><td align="center" rowspan="1" colspan="1">0.31</td><td align="center" rowspan="1" colspan="1">0.88</td></tr><tr><td align="center" rowspan="1" colspan="1">Total Calorie (g)</td><td align="center" rowspan="1" colspan="1">-513.5 &#x000b1;906.2</td><td align="center" rowspan="1" colspan="1">0.05</td><td align="center" rowspan="1" colspan="1">-432.9 &#x000b1;276.9</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">0.89</td></tr><tr><td align="center" rowspan="1" colspan="1">Oleic acid (g)</td><td align="center" rowspan="1" colspan="1">-9.4 &#x000b1;21.0</td><td align="center" rowspan="1" colspan="1">0.12</td><td align="center" rowspan="1" colspan="1">-6.8 &#x000b1;5.3</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.01</td><td align="center" rowspan="1" colspan="1">0.73</td></tr><tr><td align="center" rowspan="1" colspan="1">Linoleic acid (g)</td><td align="center" rowspan="1" colspan="1">-5.1 &#x000b1;9.8</td><td align="center" rowspan="1" colspan="1">0.07</td><td align="center" rowspan="1" colspan="1">-3.6 &#x000b1;4.3</td><td align="center" rowspan="1" colspan="1">0.02</td><td align="center" rowspan="1" colspan="1">0.87</td></tr><tr><td align="center" rowspan="1" colspan="1">Total Fat (g)</td><td align="center" rowspan="1" colspan="1">-25.5 &#x000b1;52.4</td><td align="center" rowspan="1" colspan="1">0.09</td><td align="center" rowspan="1" colspan="1">-17.0 &#x000b1;14.3</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.01</td><td align="center" rowspan="1" colspan="1">0.95</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t005fn001"><p>Direction of improvement: (+) a high score is desirable, (-) a low score is desirable<sup>&#x02020;</sup>Based upon ANCOVA covarying for baseline measure and baseline diastolic blood pressure.</p></fn></table-wrap-foot></table-wrap><p>The SR group showed significant within-group reductions in dietary intake of sodium and protein. The EHE group reported significant within-group reductions in dietary intake of sodium, protein, carbohydrate, total calories, total fat, oleic acid and linoleic acid. There were no significant between-group differences in these lifestyle factors.</p><p>There were no significant within or between-group changes in telomere length (SR group = -0.05 &#x000b1; 0.5 relative units; <italic>p</italic> value = 0.61 and EHE group = -0.02 &#x000b1; 0.5 relative units; <italic>p</italic> value = 0.84; between group <italic>p</italic> value = 0.39).</p><p>Intervention meeting attendance was the first measure of compliance with the study interventions. In the stress reduction group, participants attended an average 87% of the Transcendental Meditation instructional meetings and 88.5% of the basic health education meetings over the course of 16 weeks. In the extensive health education group, participants attended 88% of the lifestyle modification education and support meetings over 16 weeks. Second, 92% of the SR group reported practicing the TM technique at home at least once per day. The average number of home practice sessions per day was 1.6.</p></sec><sec sec-type="conclusions" id="sec021"><title>Discussion</title><p>Psychosocial stress, physical inactivity, obesity, excessive dietary sodium and alcohol intake may contribute to hypertension [<xref rid="pone.0142689.ref037" ref-type="bibr">37</xref>,<xref rid="pone.0142689.ref038" ref-type="bibr">38</xref>]. Psychological stress also induces inflammation and oxidative stress and activates the sympathetic nervous system and HPA axis [<xref rid="pone.0142689.ref014" ref-type="bibr">14</xref>,<xref rid="pone.0142689.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0142689.ref039" ref-type="bibr">39</xref>]. Several previous trials of nonpharmacological interventions indicate that lifestyle modifications may reduce chronically elevated BP [<xref rid="pone.0142689.ref037" ref-type="bibr">37</xref>,<xref rid="pone.0142689.ref040" ref-type="bibr">40</xref>,<xref rid="pone.0142689.ref041" ref-type="bibr">41</xref>,<xref rid="pone.0142689.ref042" ref-type="bibr">42</xref>]. In the present study, we compared the efficacy of two behavioral lifestyle modification interventions for hypertension: a stress reduction-based program (SR) that included the Transcendental Meditation technique and second, an extensive health education program (EHE) in African American men and women with stage I hypertension. Both the stress reduction and extensive health education groups showed increased telomerase gene expression and reduced BP and over 16 weeks.</p><p>The reductions in systolic BP of 5&#x02013;10 mm Hg in both groups are consistent with previously published literature reporting that conventional lifestyle modification (e.g. salt restriction, aerobic exercise, weight loss) and practice of the Transcendental Meditation technique are effective in lowering high BP with average changes in this range [<xref rid="pone.0142689.ref017" ref-type="bibr">17</xref>,<xref rid="pone.0142689.ref018" ref-type="bibr">18</xref>,<xref rid="pone.0142689.ref019" ref-type="bibr">19</xref>,<xref rid="pone.0142689.ref040" ref-type="bibr">40</xref>,<xref rid="pone.0142689.ref041" ref-type="bibr">41</xref>,<xref rid="pone.0142689.ref042" ref-type="bibr">42</xref>]. In this trial, systolic BP decreased in both the SR and EHE groups, although there was no significant difference in the change between groups. The EHE group showed a significant within-group reduction of -5 mm Hg in diastolic BP, while the reduction in the SR group was not significant (-1 mm Hg).</p><p>Both groups reported changes in lifestyle factors related to BP, including lower levels of self-reported sodium intake (300&#x02013;600 mg/day) and protein (12&#x02013;14 g/day); however the extensive health education group showed a greater number of dietary changes including reduced intakes of calories, carbohydrate, and fat than the stress reduction group. It may be that EHE group was motivated for more extensive dietary modifications due to active reinforcement of lifestyle change through the additional program of motivational videos, field trips and social support groups.</p><p>Many studies have found that African Americans patients are on average sensitive to the blood pressure-lowering effects of sodium intake [<xref rid="pone.0142689.ref043" ref-type="bibr">43</xref>]. Depending on the baseline blood pressure and degree of sodium intake of reduction, systolic blood pressure may be lowered by 4 to 8 mm Hg. A greater decrease in blood pressure is achieved when reduced sodium intake is combined with other lifestyle interventions [<xref rid="pone.0142689.ref043" ref-type="bibr">43</xref>,<xref rid="pone.0142689.ref044" ref-type="bibr">44</xref>]. In the SR group, practicing the TM technique may have reduced sympathetic nervous system activation which is associated with hypertension [<xref rid="pone.0142689.ref045" ref-type="bibr">45</xref>,<xref rid="pone.0142689.ref046" ref-type="bibr">46</xref>]. A number of studies demonstrate that the sympathetic nervous system may play a role in hypertension, in part by mediating salt sensitivity [<xref rid="pone.0142689.ref045" ref-type="bibr">45</xref>][<xref rid="pone.0142689.ref047" ref-type="bibr">47</xref>]. This is based on the findings that many salt-sensitive subjects have higher levels of norepinephrine and decreased dopamine. Norepinephrine is associated with sodium retention and dopamine promotes increased sodium excretion [<xref rid="pone.0142689.ref045" ref-type="bibr">45</xref>,<xref rid="pone.0142689.ref047" ref-type="bibr">47</xref>].</p><p>Concurrently, the SR and EHE groups each showed within-group increases in expression of the telomerase genes, <italic>hTR and hTERT</italic>. There were similar changes in both intervention groups. Telomerase RNA (<italic>hTR</italic>) along with telomerase reverse transcriptase protein (<italic>hTERT</italic>) is combined in vitro to reconstitute telomere synthesis. Hence, both these are necessary for telomere synthesis and are determinants of telomere length [<xref rid="pone.0142689.ref048" ref-type="bibr">48</xref>]. To support the importance of <italic>hTERT</italic> in telomere maintenance, tissue culture studies have demonstrated that introducing exogenous <italic>hTERT</italic> into primary cells results in the induction of telomere maintenance and escape of cells from senescence [<xref rid="pone.0142689.ref049" ref-type="bibr">49</xref>,<xref rid="pone.0142689.ref050" ref-type="bibr">50</xref>]. Introducing exogenous <italic>hTERT</italic> has also been shown to protect cells from stress-induced apoptosis and necrosis, thereby delaying cellular senescence and cell death [<xref rid="pone.0142689.ref051" ref-type="bibr">51</xref>]. The <italic>hTR</italic> component is also considered an essential requirement for telomere maintenance and telomerase activity in normal tissues and disease [<xref rid="pone.0142689.ref023" ref-type="bibr">23</xref>].</p><p>Clinical associations have been observed between low telomerase levels, short telomere length and hypertension. It has been hypothesized that telomere biology may play a pathophysiological role in the development of hypertension [<xref rid="pone.0142689.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0142689.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0142689.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0142689.ref012" ref-type="bibr">12</xref>,<xref rid="pone.0142689.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0142689.ref052" ref-type="bibr">52</xref>,<xref rid="pone.0142689.ref053" ref-type="bibr">53</xref>]. In this study, the two intervention groups exhibited both increased telomerase gene expression and reduced BP. These results are consistent with the hypotheses that either an increase in telomerase gene expression is a biomarker for effects of meditation and lifestyle modification in hypertension or that increases in telomerase gene expression may be part of the molecular pathway that causally lowers BP. Verification of whether this association of telomerase and BP is a biomarker or causal link requires considerably more experimental investigation.</p><p>Several previous studies have examined the relationship between telomerase, telomere length, BP and cardiovascular hemodynamics&#x02014;although these did not include antihypertensive interventions[<xref rid="pone.0142689.ref053" ref-type="bibr">53</xref>]. Findings from Jeanclos <italic>et al</italic>.[<xref rid="pone.0142689.ref054" ref-type="bibr">54</xref>] showed that pulse pressure was inversely correlated with telomere length in white blood cells (WBCs), suggesting an inverse correlation between telomere length and pulse pressure. Furthermore, in a cross-sectional study comparing hypertensive and normotensives, it was shown that the systolic and diastolic blood pressure negatively correlated with relative telomere length [<xref rid="pone.0142689.ref055" ref-type="bibr">55</xref>]. In another study using a mouse model, it was shown that inducing changes in the phenotypic expression of vascular walls both predisposed to development of hypertension and resulted in shortening of telomere length [<xref rid="pone.0142689.ref013" ref-type="bibr">13</xref>]. A study by Benetos <italic>et al</italic> [<xref rid="pone.0142689.ref056" ref-type="bibr">56</xref>] found in multivariate analysis that telomere shortening was significantly associated with increased pulse pressure and pulse wave velocity in men.</p><p>Many studies have found that chronic psychosocial stress is associated with decreased telomerase activity [<xref rid="pone.0142689.ref052" ref-type="bibr">52</xref>,<xref rid="pone.0142689.ref057" ref-type="bibr">57</xref>,<xref rid="pone.0142689.ref058" ref-type="bibr">58</xref>]. Lifestyle modifications have been linked to increased telomerase activity. Previous research has reported effects of mind-body interventions on telomerase activity in nonhypertensive populations and/or did not report BP. Lavretsky <italic>et al</italic>. conducted a pilot trial with 39 dementia caregivers using meditation or a relaxation music control for eight weeks. Their results suggested increased telomerase activity in peripheral blood mononuclear cells (PBMC) in the experimental group compared to controls [<xref rid="pone.0142689.ref059" ref-type="bibr">59</xref>]. In another study, 30 participants in a three-month meditation retreat and showed higher levels of telomerase activity in their PBMCs compared to the wait-list controls [<xref rid="pone.0142689.ref060" ref-type="bibr">60</xref>]. Dusek <italic>et al</italic>. studied the effects of relaxation on genome-wide gene expression in a general population sample, but did not report <italic>hTR</italic> or <italic>hTERT</italic> RNA levels [<xref rid="pone.0142689.ref061" ref-type="bibr">61</xref>]. In addition to not examining or reporting relationships of gene expression, telomerase and cardiovascular outcomes (ie, BP), none of these studies focused on high risk racial/ethnic populations.</p><p>In practical clinical settings, concerns have been raised about compliance with lifestyle modification interventions [<xref rid="pone.0142689.ref062" ref-type="bibr">62</xref>,<xref rid="pone.0142689.ref063" ref-type="bibr">63</xref>,<xref rid="pone.0142689.ref064" ref-type="bibr">64</xref>]. For example, Hamer comments that, &#x0201c;Despite the wealth of evidence regarding the benefits of healthy lifestyle, the available data suggest that adherence to these recommendations among hypertensive patients is poor.&#x0201d; (Hamer, 2010)[<xref rid="pone.0142689.ref062" ref-type="bibr">62</xref>]. By contrast, 92% of the patients in the stress reduction group in this study reported practicing the Transcendental Meditation technique at least once per day at home. The average home practice frequency was 1.6 times per day. The adherence findings from this 16 week trial compare favorably with long-term adherence to TM practice reported over an average of five years in a trial of patients with coronary heart disease [<xref rid="pone.0142689.ref065" ref-type="bibr">65</xref>]. These data suggest that this form of stress reduction is clinically feasible with relatively high adherence. There was no significant change in physical activity in either group. Self reported changes in diet are discussed above.</p><p>There are several limitations of the present study. The first was the lack of an inactive control group. To address this limitation, future research might use a three-arm design, including an inactive or placebo control group. On the other hand, the current pilot trial may be considered a comparative effectiveness study of two clinical programs, both of which have been recommended for consideration in the treatment of hypertension [<xref rid="pone.0142689.ref036" ref-type="bibr">36</xref>,<xref rid="pone.0142689.ref041" ref-type="bibr">41</xref>,<xref rid="pone.0142689.ref042" ref-type="bibr">42</xref>,<xref rid="pone.0142689.ref046" ref-type="bibr">46</xref>,<xref rid="pone.0142689.ref066" ref-type="bibr">66</xref>]. The second limitation involved the use of multimodality therapies in each comparison group. This design however, reflects clinical practice pragmatics and enhances external validity of the study [<xref rid="pone.0142689.ref067" ref-type="bibr">67</xref>].</p><p>Another limitation was the relatively small sample size of 48. Although there were significant increases in <italic>hTERT</italic> and <italic>hTR</italic> gene expression within each of the two lifestyle modification groups, the results indicated that there were no significant differences between the two groups studied. A larger sample size would generate the statistical power needed to either confirm or disprove these findings.</p><p>There were no statistically significant differences in telomere length within or between groups. Telomere length is usually not sensitive to short-term interventions, such as the 16 weeks in the present study, but may require a year or more for detectable changes to be observed [<xref rid="pone.0142689.ref068" ref-type="bibr">68</xref>]. Thus, a longer term, prospective trial is needed to determine effects of antihypertensive lifestyle modifications, including stress reduction on telomere length.</p><p>We also did not find significant changes for anger expression either between or within groups. Recent meta-analysis of psychological effects of the Transcendental Meditation technique have reported reductions in anxiety [<xref rid="pone.0142689.ref069" ref-type="bibr">69</xref>,<xref rid="pone.0142689.ref070" ref-type="bibr">70</xref>] and a long term trial in CHD patients found reduced anger expression over an average of five years follow up [<xref rid="pone.0142689.ref065" ref-type="bibr">65</xref>]. It may be that anger is a less sensitive marker of meditation over the short-term compared to long-term follow up. Anxiety may be more sensitive short-term psychological marker, although it was not measured in the current study.</p><p>In this study, we have used whole blood samples to determine the telomerase activity. One of the risks of using whole blood samples is that the proportions of different types of white blood cells, in particular T cells and B cells, among subjects. It is known that these cell types vary in telomere length. Therefore, if the cell-type composition varies from subject to subject, it could affect the levels of measured telomerase [<xref rid="pone.0142689.ref071" ref-type="bibr">71</xref>] Various levels of hTR and hTERT have been observed to be upregulated when T and B cells are activated but to date this has been observed only in studies in which activation has been done for experimental purposes.[<xref rid="pone.0142689.ref072" ref-type="bibr">72</xref>]</p><p>The larger parent trial was a randomized controlled trial. However, this ancillary study comprised volunteers from each group after they had been randomized. Therefore, this pilot trial was not a randomized trial, although its sample was drawn from an RCT. The experimental design may be considered a quasi-randomized trial [<xref rid="pone.0142689.ref073" ref-type="bibr">73</xref>]. Future studies should prospectively employ a random allocation design to the study of stress reduction, lifestyle modification and telomere biology. Finally, this pilot trial was limited to a single racial/ethnic sample of African Americans. Follow up trials involving other populations would provide evidence about the generalizability of these findings.</p><p>
<underline>In conclusion,</underline> this pilot trial compared a stress reduction program based on the Transcendental Meditation technique to an extensive health education intervention in African American patients with stage I hypertension. Both interventions demonstrated increased telomerase gene expression and reduced BP. The results suggest molecular biomarkers or mechanisms of these two lifestyle modification approaches in the treatment of hypertension.</p></sec><sec sec-type="supplementary-material" id="sec022"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0142689.s001"><label>S1 CONSORT Checklist</label><caption><title>CONSORT checklist of information to include when reporting a randomised trial.</title><p>(DOC)</p></caption><media xlink:href="pone.0142689.s001.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0142689.s002"><label>S1 Protocol</label><caption><title>Research Design and Methods for parent study.</title><p>(DOCX)</p></caption><media xlink:href="pone.0142689.s002.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0142689.s003"><label>S1 Table</label><caption><title>Inclusion of subjects who participated in the telomerase substudy compared to those who did not.</title><p>(DOCX)</p></caption><media xlink:href="pone.0142689.s003.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We like to thank Dr. Meera Srivastava and Dr. Fred Travis, for their valuable suggestions on the research. Linda Heaton, Laura Alcorn and Carol Jarvis provided administrative support. <bold>Funding:</bold> This study was supported by grants from the NIH-National Heart Lung and Blood Institute #HL083944; and the Howard University College of Medicine General Clinical Research Center #MO1 RR10284. Global ID Group provided scholarship support to Dr. Shanthi Lakshman Duraimani for her PhD studies. <bold>Disclosures:</bold> Dr. Fagan was Chief Scientific Officer at Global ID Group, which provides commercial GMO testing services until November 2013. Since then, Dr. Fagan has no financial, professional, or personal affiliation with Global ID Group and no competing interests.</p></ack><ref-list><title>References</title><ref id="pone.0142689.ref001"><label>1</label><mixed-citation publication-type="journal">
<name><surname>Aronow</surname><given-names>WS</given-names></name> (<year>2012</year>) <article-title>Treatment of systemic hypertension</article-title>. <source>Am J Cardiovasc Dis</source>
<volume>2</volume>: <fpage>160</fpage>&#x02013;<lpage>170</lpage>.
<pub-id pub-id-type="pmid">22937486</pub-id></mixed-citation></ref><ref id="pone.0142689.ref002"><label>2</label><mixed-citation publication-type="journal">
<name><surname>Lewington</surname><given-names>S</given-names></name>, <name><surname>Clarke</surname><given-names>R</given-names></name>, <name><surname>Qizilbash</surname><given-names>N</given-names></name>, <name><surname>Peto</surname><given-names>R</given-names></name>, <name><surname>Collins</surname><given-names>R</given-names></name> (<year>2002</year>) <article-title>Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies</article-title>. <source>Lancet</source>
<volume>360</volume>: <fpage>1903</fpage>&#x02013;<lpage>1913</lpage>.
<pub-id pub-id-type="pmid">12493255</pub-id></mixed-citation></ref><ref id="pone.0142689.ref003"><label>3</label><mixed-citation publication-type="journal">
<name><surname>Sheats</surname><given-names>N</given-names></name>, <name><surname>Lin</surname><given-names>Y</given-names></name>, <name><surname>Zhao</surname><given-names>W</given-names></name>, <name><surname>Cheek</surname><given-names>DE</given-names></name>, <name><surname>Lackland</surname><given-names>DT</given-names></name>, <name><surname>Egan</surname><given-names>BM</given-names></name> (<year>2005</year>) <article-title>Prevalence, treatment, and control of hypertension among African Americans and Caucasians at primary care sites for medically under-served patients</article-title>. <source>Ethn Dis</source>
<volume>15</volume>: <fpage>25</fpage>&#x02013;<lpage>32</lpage>.
<pub-id pub-id-type="pmid">15720046</pub-id></mixed-citation></ref><ref id="pone.0142689.ref004"><label>4</label><mixed-citation publication-type="journal">
<name><surname>Ferdinand</surname><given-names>KC</given-names></name>, <name><surname>Armani</surname><given-names>AM</given-names></name> (<year>2007</year>) <article-title>The management of hypertension in African Americans</article-title>. <source>Crit Pathw Cardiol</source>
<volume>6</volume>: <fpage>67</fpage>&#x02013;<lpage>71</lpage>.
<pub-id pub-id-type="pmid">17667868</pub-id></mixed-citation></ref><ref id="pone.0142689.ref005"><label>5</label><mixed-citation publication-type="journal">
<name><surname>Martins</surname><given-names>D</given-names></name>, <name><surname>Norris</surname><given-names>K</given-names></name> (<year>2004</year>) <article-title>Hypertension treatment in African Americans: physiology is less important than sociology</article-title>. <source>Cleve Clin J Med</source>
<volume>71</volume>: <fpage>735</fpage>&#x02013;<lpage>743</lpage>.
<pub-id pub-id-type="pmid">15478705</pub-id></mixed-citation></ref><ref id="pone.0142689.ref006"><label>6</label><mixed-citation publication-type="journal">
<name><surname>Barnes</surname><given-names>VA</given-names></name>, <name><surname>Schneider</surname><given-names>RH</given-names></name>, <name><surname>Alexander</surname><given-names>CN</given-names></name>, <name><surname>Staggers</surname><given-names>F</given-names></name> (<year>1997</year>) <article-title>Stress, stress reduction and hypertension in African Americans: An updated review</article-title>. <source>J Natl Med Assoc</source>
<volume>89</volume>: <fpage>464</fpage>&#x02013;<lpage>476</lpage>.
<pub-id pub-id-type="pmid">9220696</pub-id></mixed-citation></ref><ref id="pone.0142689.ref007"><label>7</label><mixed-citation publication-type="journal">
<name><surname>Brondolo</surname><given-names>E</given-names></name>, <name><surname>Love</surname><given-names>EE</given-names></name>, <name><surname>Pencille</surname><given-names>M</given-names></name>, <name><surname>Schoenthaler</surname><given-names>A</given-names></name>, <name><surname>Ogedegbe</surname><given-names>G</given-names></name> (<year>2011</year>) <article-title>Racism and hypertension: a review of the empirical evidence and implications for clinical practice</article-title>. <source>Am J Hypertens</source>
<volume>24</volume>: <fpage>518</fpage>&#x02013;<lpage>529</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ajh.2011.9">10.1038/ajh.2011.9</ext-link></comment>
<pub-id pub-id-type="pmid">21331054</pub-id></mixed-citation></ref><ref id="pone.0142689.ref008"><label>8</label><mixed-citation publication-type="journal">
<name><surname>Sims</surname><given-names>M</given-names></name>, <name><surname>Diez-Roux</surname><given-names>AV</given-names></name>, <name><surname>Dudley</surname><given-names>A</given-names></name>, <name><surname>Gebreab</surname><given-names>S</given-names></name>, <name><surname>Wyatt</surname><given-names>SB</given-names></name>, <name><surname>Bruce</surname><given-names>MA</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Perceived discrimination and hypertension among African Americans in the Jackson Heart Study</article-title>. <source>Am J Public Health</source>
<volume>102</volume>
<issue>Suppl 2</issue>: <fpage>S258</fpage>&#x02013;<lpage>265</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2105/AJPH.2011.300523">10.2105/AJPH.2011.300523</ext-link></comment>
<pub-id pub-id-type="pmid">22401510</pub-id></mixed-citation></ref><ref id="pone.0142689.ref009"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Serrano</surname><given-names>AL</given-names></name>, <name><surname>Andres</surname><given-names>V</given-names></name> (<year>2004</year>) <article-title>Telomeres and cardiovascular disease: does size matter?</article-title>
<source>Circ Res</source>
<volume>94</volume>: <fpage>575</fpage>&#x02013;<lpage>584</lpage>.
<pub-id pub-id-type="pmid">15031270</pub-id></mixed-citation></ref><ref id="pone.0142689.ref010"><label>10</label><mixed-citation publication-type="journal">
<name><surname>Vasan</surname><given-names>RS</given-names></name>, <name><surname>Demissie</surname><given-names>S</given-names></name>, <name><surname>Kimura</surname><given-names>M</given-names></name>, <name><surname>Cupples</surname><given-names>LA</given-names></name>, <name><surname>Rifai</surname><given-names>N</given-names></name>, <name><surname>White</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Association of leukocyte telomere length with circulating biomarkers of the renin-angiotensin-aldosterone system: the Framingham Heart Study</article-title>. <source>Circulation</source>
<volume>117</volume>: <fpage>1138</fpage>&#x02013;<lpage>1144</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/CIRCULATIONAHA.107.731794">10.1161/CIRCULATIONAHA.107.731794</ext-link></comment>
<pub-id pub-id-type="pmid">18268147</pub-id></mixed-citation></ref><ref id="pone.0142689.ref011"><label>11</label><mixed-citation publication-type="journal">
<name><surname>Yang</surname><given-names>Z</given-names></name>, <name><surname>Huang</surname><given-names>X</given-names></name>, <name><surname>Jiang</surname><given-names>H</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Liu</surname><given-names>H</given-names></name>, <name><surname>Qin</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Short telomeres and prognosis of hypertension in a chinese population</article-title>. <source>Hypertension</source>
<volume>53</volume>: <fpage>639</fpage>&#x02013;<lpage>645</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/HYPERTENSIONAHA.108.123752">10.1161/HYPERTENSIONAHA.108.123752</ext-link></comment>
<pub-id pub-id-type="pmid">19255364</pub-id></mixed-citation></ref><ref id="pone.0142689.ref012"><label>12</label><mixed-citation publication-type="journal">
<name><surname>Baccarelli</surname><given-names>A</given-names></name>, <name><surname>Rienstra</surname><given-names>M</given-names></name>, <name><surname>Benjamin</surname><given-names>EJ</given-names></name> (<year>2010</year>) <article-title>Cardiovascular epigenetics: basic concepts and results from animal and human studies</article-title>. <source>Circ Cardiovasc Genet</source>
<volume>3</volume>: <fpage>567</fpage>&#x02013;<lpage>573</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/CIRCGENETICS.110.958744">10.1161/CIRCGENETICS.110.958744</ext-link></comment>
<pub-id pub-id-type="pmid">21156932</pub-id></mixed-citation></ref><ref id="pone.0142689.ref013"><label>13</label><mixed-citation publication-type="journal">
<name><surname>Perez-Rivero</surname><given-names>G</given-names></name>, <name><surname>Ruiz-Torres</surname><given-names>MP</given-names></name>, <name><surname>Rivas-Elena</surname><given-names>JV</given-names></name>, <name><surname>Jerkic</surname><given-names>M</given-names></name>, <name><surname>Diez-Marques</surname><given-names>ML</given-names></name>, <name><surname>Lopez-Novoa</surname><given-names>JM</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Mice deficient in telomerase activity develop hypertension because of an excess of endothelin production</article-title>. <source>Circulation</source>
<volume>114</volume>: <fpage>309</fpage>&#x02013;<lpage>317</lpage>.
<pub-id pub-id-type="pmid">16831983</pub-id></mixed-citation></ref><ref id="pone.0142689.ref014"><label>14</label><mixed-citation publication-type="journal">
<name><surname>Epel</surname><given-names>ES</given-names></name> (<year>2009</year>) <article-title>Psychological and metabolic stress: a recipe for accelerated cellular aging?</article-title>
<source>Hormones (Athens)</source>
<volume>8</volume>: <fpage>7</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">19269917</pub-id></mixed-citation></ref><ref id="pone.0142689.ref015"><label>15</label><mixed-citation publication-type="journal">
<name><surname>De Meyer</surname><given-names>T</given-names></name> (<year>2011</year>) <article-title>Telomere length integrates psychological factors in the successful aging story, but what about the biology?</article-title>
<source>Psychosom Med</source>
<volume>73</volume>: <fpage>524</fpage>&#x02013;<lpage>527</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/PSY.0b013e31822ed876">10.1097/PSY.0b013e31822ed876</ext-link></comment>
<pub-id pub-id-type="pmid">21873590</pub-id></mixed-citation></ref><ref id="pone.0142689.ref016"><label>16</label><mixed-citation publication-type="journal">
<name><surname>Epel</surname><given-names>ES</given-names></name>, <name><surname>Lin</surname><given-names>J</given-names></name>, <name><surname>Wilhelm</surname><given-names>FH</given-names></name>, <name><surname>Wolkowitz</surname><given-names>OM</given-names></name>, <name><surname>Cawthon</surname><given-names>R</given-names></name>, <name><surname>Adler</surname><given-names>NE</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Cell aging in relation to stress arousal and cardiovascular disease risk factors</article-title>. <source>Psychoneuroendocrinology</source>
<volume>31</volume>: <fpage>277</fpage>&#x02013;<lpage>287</lpage>.
<pub-id pub-id-type="pmid">16298085</pub-id></mixed-citation></ref><ref id="pone.0142689.ref017"><label>17</label><mixed-citation publication-type="journal">
<name><surname>Rainforth</surname><given-names>M</given-names></name>, <name><surname>Schneider</surname><given-names>R</given-names></name>, <name><surname>Nidich</surname><given-names>S</given-names></name>, <name><surname>King</surname><given-names>C</given-names></name>, <name><surname>Salerno</surname><given-names>J</given-names></name>, <name><surname>Anderson</surname><given-names>J</given-names></name> (<year>2007</year>) <article-title>Stress Reduction Programs in Patients with Elevated Blood Pressure: A Systematic Review and Meta-analysis</article-title>. <source>Curr Hypertens Rep</source>
<volume>9</volume>: <fpage>520</fpage>&#x02013;<lpage>528</lpage>.
<pub-id pub-id-type="pmid">18350109</pub-id></mixed-citation></ref><ref id="pone.0142689.ref018"><label>18</label><mixed-citation publication-type="journal">
<name><surname>Bai</surname><given-names>Z</given-names></name>, <name><surname>Chang</surname><given-names>J</given-names></name>, <name><surname>Chen</surname><given-names>C</given-names></name>, <name><surname>Li</surname><given-names>P</given-names></name>, <name><surname>Yang</surname><given-names>K</given-names></name>, <name><surname>Chi</surname><given-names>I</given-names></name> (<year>2015</year>) <article-title>Investigating the effect of transcendental meditation on blood pressure: a systematic review and meta-analysis</article-title>. <source>J Hum Hypertens</source>.</mixed-citation></ref><ref id="pone.0142689.ref019"><label>19</label><mixed-citation publication-type="journal">
<name><surname>Anderson</surname><given-names>J</given-names></name>, <name><surname>Liu</surname><given-names>C</given-names></name>, <name><surname>Kryscio</surname><given-names>R</given-names></name> (<year>2008</year>) <article-title>Blood Pressure Response to Transcendental Meditation: a meta-analysis</article-title>. <source>Am J Hypertens</source>
<volume>21</volume>: <fpage>310</fpage>&#x02013;<lpage>316</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ajh.2007.65">10.1038/ajh.2007.65</ext-link></comment>
<pub-id pub-id-type="pmid">18311126</pub-id></mixed-citation></ref><ref id="pone.0142689.ref020"><label>20</label><mixed-citation publication-type="journal">
<name><surname>Ornish</surname><given-names>D</given-names></name>, <name><surname>Magbanua</surname><given-names>MJ</given-names></name>, <name><surname>Weidner</surname><given-names>G</given-names></name>, <name><surname>Weinberg</surname><given-names>V</given-names></name>, <name><surname>Kemp</surname><given-names>C</given-names></name>, <name><surname>Green</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>105</volume>: <fpage>8369</fpage>&#x02013;<lpage>8374</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.0803080105">10.1073/pnas.0803080105</ext-link></comment>
<pub-id pub-id-type="pmid">18559852</pub-id></mixed-citation></ref><ref id="pone.0142689.ref021"><label>21</label><mixed-citation publication-type="journal">
<name><surname>Schultz</surname><given-names>K</given-names></name>, <name><surname>Altman</surname><given-names>D</given-names></name>, <name><surname>Moher</surname><given-names>D</given-names></name> (<year>2010</year>) <article-title>CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials</article-title>. <source>BMJ</source>
<volume>340</volume>: <fpage>332</fpage>.</mixed-citation></ref><ref id="pone.0142689.ref022"><label>22</label><mixed-citation publication-type="journal">
<name><surname>Abramson</surname><given-names>J</given-names></name>, <name><surname>Berger</surname><given-names>A</given-names></name>, <name><surname>Krumholz</surname><given-names>HM</given-names></name>, <name><surname>Vaccarino</surname><given-names>V</given-names></name> (<year>2001</year>) <article-title>Depression and risk of heart failure among older persons with isolated systolic hypertension</article-title>. <source>Arch Intern Med</source>
<volume>161</volume>: <fpage>1725</fpage>&#x02013;<lpage>1730</lpage>.
<pub-id pub-id-type="pmid">11485505</pub-id></mixed-citation></ref><ref id="pone.0142689.ref023"><label>23</label><mixed-citation publication-type="journal">
<name><surname>Keith</surname><given-names>WN</given-names></name>, <name><surname>Thomson</surname><given-names>CM</given-names></name>, <name><surname>Howcroft</surname><given-names>J</given-names></name>, <name><surname>Maitland</surname><given-names>NJ</given-names></name>, <name><surname>Shay</surname><given-names>JW</given-names></name> (<year>2007</year>) <article-title>Seeding drug discovery: integrating telomerase cancer biology and cellular senescence to uncover new therapeutic opportunities in targeting cancer stem cells</article-title>. <source>Drug Discov Today</source>
<volume>12</volume>: <fpage>611</fpage>&#x02013;<lpage>621</lpage>.
<pub-id pub-id-type="pmid">17706542</pub-id></mixed-citation></ref><ref id="pone.0142689.ref024"><label>24</label><mixed-citation publication-type="journal">
<name><surname>Yajima</surname><given-names>T</given-names></name>, <name><surname>Yagihashi</surname><given-names>A</given-names></name>, <name><surname>Kameshima</surname><given-names>H</given-names></name>, <name><surname>Furuya</surname><given-names>D</given-names></name>, <name><surname>Kobayashi</surname><given-names>D</given-names></name>, <name><surname>Hirata</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>Establishment of quantitative reverse transcription&#x02014;polymerase chain reaction assays for human telomerase-associated genes</article-title>. <source>Clin Chim Acta</source>
<volume>290</volume>: <fpage>117</fpage>&#x02013;<lpage>127</lpage>.
<pub-id pub-id-type="pmid">10660803</pub-id></mixed-citation></ref><ref id="pone.0142689.ref025"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Cawthon</surname><given-names>RM</given-names></name>, <name><surname>Smith</surname><given-names>KR</given-names></name>, <name><surname>O'Brien</surname><given-names>E</given-names></name>, <name><surname>Sivatchenko</surname><given-names>A</given-names></name>, <name><surname>Kerber</surname><given-names>RA</given-names></name> (<year>2003</year>) <article-title>Association between telomere length in blood and mortality in people aged 60 years or older</article-title>. <source>Lancet</source>
<volume>361</volume>: <fpage>393</fpage>&#x02013;<lpage>395</lpage>.
<pub-id pub-id-type="pmid">12573379</pub-id></mixed-citation></ref><ref id="pone.0142689.ref026"><label>26</label><mixed-citation publication-type="journal">
<name><surname>Boucher</surname><given-names>B</given-names></name>, <name><surname>Cotterchio</surname><given-names>M</given-names></name>, <name><surname>Kreiger</surname><given-names>N</given-names></name>, <name><surname>Nadalin</surname><given-names>V</given-names></name>, <name><surname>Block</surname><given-names>T</given-names></name>, <name><surname>Block</surname><given-names>G</given-names></name> (<year>2006</year>) <article-title>Validity and reliability of the Block 98 food-frequency questionnaire in a sample of Canadian women</article-title>. <source>Public Health Nutr</source>
<volume>9</volume>: <fpage>84</fpage>&#x02013;<lpage>93</lpage>.
<pub-id pub-id-type="pmid">16480538</pub-id></mixed-citation></ref><ref id="pone.0142689.ref027"><label>27</label><mixed-citation publication-type="book">
<name><surname>Spielberger</surname><given-names>C</given-names></name>, <name><surname>Sydeman</surname><given-names>S</given-names></name>, <name><surname>Owen</surname><given-names>A</given-names></name>, <name><surname>Marsh</surname><given-names>B</given-names></name> (<year>1999</year>) <chapter-title>Measuring anxiety and anger with the State-Trait Anxiety Inventory (STAI) and the State-Trait Anger Expression Inventory (STAXI)</chapter-title> In: <name><surname>Maruish</surname><given-names>M</given-names></name>, editor. <source>The use of psychological testing for treatment planning and outcomes assessment</source>. <edition>2nd ed.</edition>
<publisher-loc>Mahwah, NJ</publisher-loc>: <publisher-name>Lawrence Erlbaum Associates</publisher-name> pp. <fpage>1507</fpage>.</mixed-citation></ref><ref id="pone.0142689.ref028"><label>28</label><mixed-citation publication-type="journal">
<name><surname>Folsom</surname><given-names>AR</given-names></name>, <name><surname>Caspersen</surname><given-names>CJ</given-names></name>, <name><surname>Taylor</surname><given-names>HL</given-names></name>, <name><surname>Jacobs</surname><given-names>DR</given-names><suffix>Jr</suffix></name>, <name><surname>Luepker</surname><given-names>RV</given-names></name>, <name><surname>Gomez-Marin</surname><given-names>O</given-names></name>, <etal>et al</etal> (<year>1985</year>) <article-title>Leisure time physical activity and its relationship to coronary risk factors in a population-based sample. The Minnesota Heart Survey</article-title>. <source>Am J Epidemiol</source>
<volume>121</volume>: <fpage>570</fpage>&#x02013;<lpage>579</lpage>.
<pub-id pub-id-type="pmid">4014146</pub-id></mixed-citation></ref><ref id="pone.0142689.ref029"><label>29</label><mixed-citation publication-type="journal">
<name><surname>Jevning</surname><given-names>R</given-names></name>, <name><surname>Wallace</surname><given-names>RK</given-names></name>, <name><surname>Biedebach</surname><given-names>M</given-names></name> (<year>1992</year>) <article-title>The physiology of meditation: A review. A wakeful hypometabolic integrated response</article-title>. <source>Neurosci Biobehav Rev</source>
<volume>16</volume>: <fpage>415</fpage>&#x02013;<lpage>424</lpage>.
<pub-id pub-id-type="pmid">1528528</pub-id></mixed-citation></ref><ref id="pone.0142689.ref030"><label>30</label><mixed-citation publication-type="book">
<name><surname>Rosenthal</surname><given-names>N</given-names></name> (<year>2011</year>) <source>Transcendence: Healing and Transformation Through Transcendental Meditation</source>. <publisher-loc>NYC, New York</publisher-loc>: <publisher-name>Penguin-Tarcher</publisher-name>.</mixed-citation></ref><ref id="pone.0142689.ref031"><label>31</label><mixed-citation publication-type="book">
<name><surname>Orme-Johnson</surname><given-names>DW</given-names></name>, <name><surname>Barnes</surname><given-names>VA</given-names></name>, <name><surname>Schneider</surname><given-names>R</given-names></name> (<year>2012</year>) <chapter-title>Transcendental Meditation for primary and secondary prevention of coronary heart disease</chapter-title> In: <name><surname>Allan</surname><given-names>R</given-names></name>, <name><surname>Fisher</surname><given-names>J</given-names></name>, editors. <source>Heart &#x00026; Mind: the Practice of Cardiac Psychology</source>, <edition>second edition</edition>
<publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Psychological Association</publisher-name> pp. <fpage>365</fpage>&#x02013;<lpage>379</lpage>.</mixed-citation></ref><ref id="pone.0142689.ref032"><label>32</label><mixed-citation publication-type="book">
<name><surname>Roth</surname><given-names>R</given-names></name> (<year>2002</year>) <source>Maharishi Mahesh Yogi's Transcendental Meditation</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>Primus</publisher-name>. 90&#x02013;102 p.</mixed-citation></ref><ref id="pone.0142689.ref033"><label>33</label><mixed-citation publication-type="journal">
<name><surname>Travis</surname><given-names>F</given-names></name> (<year>2001</year>) <article-title>Autonomic and EEG patterns distinguish transcending from other experiences during Transcendental Meditation practice</article-title>. <source>Int J Psychophysiol</source>
<volume>42</volume>
<fpage>1</fpage>&#x02013;<lpage>9</lpage>.
<pub-id pub-id-type="pmid">11451476</pub-id></mixed-citation></ref><ref id="pone.0142689.ref034"><label>34</label><mixed-citation publication-type="journal">
<name><surname>Travis</surname><given-names>F</given-names></name>, <name><surname>Shear</surname><given-names>J</given-names></name> (<year>2010</year>) <article-title>Focused attention, open monitoring and automatic self-transcending: Categories to organize meditations from Vedic, Buddhist and Chinese traditions</article-title>. <source>Conscious Cogn</source>
<volume>19</volume>: <fpage>1110</fpage>&#x02013;<lpage>1118</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.concog.2010.01.007">10.1016/j.concog.2010.01.007</ext-link></comment>
<pub-id pub-id-type="pmid">20167507</pub-id></mixed-citation></ref><ref id="pone.0142689.ref035"><label>35</label><mixed-citation publication-type="journal">
<name><surname>Chobanian</surname><given-names>A</given-names></name>, <name><surname>Bakris</surname><given-names>G</given-names></name>, <name><surname>Black</surname><given-names>H</given-names></name>, <collab>National High Blood Pressure Education Program Coordinating Committee</collab> (<year>2003</year>) <article-title>The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure</article-title>. <source>JAMA</source>
<volume>289</volume>: <fpage>2560</fpage>&#x02013;<lpage>2572</lpage>.
<pub-id pub-id-type="pmid">12748199</pub-id></mixed-citation></ref><ref id="pone.0142689.ref036"><label>36</label><mixed-citation publication-type="journal">
<name><surname>Appel</surname><given-names>LJ</given-names></name>, <name><surname>Brands</surname><given-names>MW</given-names></name>, <name><surname>Daniels</surname><given-names>SR</given-names></name>, <name><surname>Karanja</surname><given-names>N</given-names></name>, <name><surname>Elmer</surname><given-names>PJ</given-names></name>, <name><surname>Sacks</surname><given-names>FM</given-names></name> (<year>2006</year>) <article-title>Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association</article-title>. <source>Hypertension</source>
<volume>47</volume>: <fpage>296</fpage>&#x02013;<lpage>308</lpage>.
<pub-id pub-id-type="pmid">16434724</pub-id></mixed-citation></ref><ref id="pone.0142689.ref037"><label>37</label><mixed-citation publication-type="journal">
<name><surname>Dickinson</surname><given-names>HO</given-names></name>, <name><surname>Mason</surname><given-names>JM</given-names></name>, <name><surname>Nicolson</surname><given-names>DJ</given-names></name>, <name><surname>Campbell</surname><given-names>F</given-names></name>, <name><surname>Beyer</surname><given-names>FR</given-names></name>, <name><surname>Cook</surname><given-names>JV</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials</article-title>. <source>J Hypertens</source>
<volume>24</volume>: <fpage>215</fpage>&#x02013;<lpage>233</lpage>.
<pub-id pub-id-type="pmid">16508562</pub-id></mixed-citation></ref><ref id="pone.0142689.ref038"><label>38</label><mixed-citation publication-type="journal">
<name><surname>Whelton</surname><given-names>SP</given-names></name>, <name><surname>Chin</surname><given-names>A</given-names></name>, <name><surname>Xin</surname><given-names>X</given-names></name>, <name><surname>He</surname><given-names>J</given-names></name> (<year>2002</year>) <article-title>Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials</article-title>. <source>Ann Intern Med</source>
<volume>136</volume>: <fpage>493</fpage>&#x02013;<lpage>503</lpage>.
<pub-id pub-id-type="pmid">11926784</pub-id></mixed-citation></ref><ref id="pone.0142689.ref039"><label>39</label><mixed-citation publication-type="journal">
<name><surname>Bairey-Merz</surname><given-names>NC</given-names></name>, <name><surname>Dwyer</surname><given-names>J</given-names></name>, <name><surname>Nordstrom</surname><given-names>CK</given-names></name>, <name><surname>Walton</surname><given-names>KG</given-names></name>, <name><surname>Salerno</surname><given-names>JW</given-names></name>, <name><surname>Schneider</surname><given-names>RH</given-names></name> (<year>2002</year>) <article-title>Psychosocial stress and cardiovascular disease: Pathophysiological links</article-title>. <source>Behav Med</source>
<volume>27</volume>: <fpage>141</fpage>&#x02013;<lpage>147</lpage>.
<pub-id pub-id-type="pmid">12165968</pub-id></mixed-citation></ref><ref id="pone.0142689.ref040"><label>40</label><mixed-citation publication-type="journal">
<name><surname>Wang</surname><given-names>M</given-names></name>, <name><surname>Moran</surname><given-names>AE</given-names></name>, <name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Qi</surname><given-names>Y</given-names></name>, <name><surname>Xie</surname><given-names>W</given-names></name>, <name><surname>Tzong</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>A Meta-Analysis of Effect of Dietary Salt Restriction on Blood Pressure in Chinese Adults</article-title>. <source>Glob Heart</source>.</mixed-citation></ref><ref id="pone.0142689.ref041"><label>41</label><mixed-citation publication-type="journal">
<name><surname>Eckel</surname><given-names>R</given-names></name>, <name><surname>Jakicic</surname><given-names>J</given-names></name>, <name><surname>Ard</surname><given-names>J</given-names></name>, <name><surname>Hubbard</surname><given-names>V</given-names></name>, <name><surname>de Jesus</surname><given-names>J</given-names></name>, <name><surname>Lee</surname><given-names>I</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines</article-title>. <source>Circulation Nov</source>.</mixed-citation></ref><ref id="pone.0142689.ref042"><label>42</label><mixed-citation publication-type="journal">
<name><surname>Brook</surname><given-names>RD</given-names></name>, <name><surname>Appel</surname><given-names>LJ</given-names></name>, <name><surname>Rubenfire</surname><given-names>M</given-names></name>, <name><surname>Ogedegbe</surname><given-names>G</given-names></name>, <name><surname>Bisognano</surname><given-names>JD</given-names></name>, <name><surname>Elliott</surname><given-names>WJ</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Beyond Medications and Diet: Alternative Approaches to Lowering Blood Pressure: A Scientific Statement From the American Heart Association</article-title>. <source>Hypertension</source>
<volume>61</volume>: <fpage>1360</fpage>&#x02013;<lpage>1383</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/HYP.0b013e318293645f">10.1161/HYP.0b013e318293645f</ext-link></comment>
<pub-id pub-id-type="pmid">23608661</pub-id></mixed-citation></ref><ref id="pone.0142689.ref043"><label>43</label><mixed-citation publication-type="journal">
<name><surname>Frisoli</surname><given-names>TM</given-names></name>, <name><surname>Schmieder</surname><given-names>RE</given-names></name>, <name><surname>Grodzicki</surname><given-names>T</given-names></name>, <name><surname>Messerli</surname><given-names>FH</given-names></name> (<year>2012</year>) <article-title>Salt and hypertension: is salt dietary reduction worth the effort?</article-title>
<source>Am J Med</source>
<volume>125</volume>: <fpage>433</fpage>&#x02013;<lpage>439</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.amjmed.2011.10.023">10.1016/j.amjmed.2011.10.023</ext-link></comment>
<pub-id pub-id-type="pmid">22482843</pub-id></mixed-citation></ref><ref id="pone.0142689.ref044"><label>44</label><mixed-citation publication-type="journal">
<name><surname>Weinberger</surname><given-names>MH</given-names></name> (<year>1996</year>) <article-title>Salt sensitivity of blood pressure in humans</article-title>. <source>Hypertension</source>
<volume>27</volume>: <fpage>481</fpage>&#x02013;<lpage>490</lpage>.
<pub-id pub-id-type="pmid">8613190</pub-id></mixed-citation></ref><ref id="pone.0142689.ref045"><label>45</label><mixed-citation publication-type="journal">
<name><surname>Palatini</surname><given-names>P</given-names></name>, <name><surname>Julius</surname><given-names>S</given-names></name> (<year>2009</year>) <article-title>The role of cardiac autonomic function in hypertension and cardiovascular disease</article-title>. <source>Curr Hypertens Rep</source>
<volume>11</volume>: <fpage>199</fpage>&#x02013;<lpage>205</lpage>.
<pub-id pub-id-type="pmid">19442329</pub-id></mixed-citation></ref><ref id="pone.0142689.ref046"><label>46</label><mixed-citation publication-type="journal">
<name><surname>Schneider</surname><given-names>R</given-names></name>, <name><surname>Carr</surname><given-names>T</given-names></name> (<year>2014</year>) <article-title>Transcendental Meditation in the prevention and treatment of cardiovascular disease and pathophysiological mechanisms: An evidence-based review</article-title>. <source>Advances in Integrative Medicine</source>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.aimed.2014.08.003">10.1016/j.aimed.2014.08.003</ext-link></comment>
</mixed-citation></ref><ref id="pone.0142689.ref047"><label>47</label><mixed-citation publication-type="journal">
<name><surname>Ely</surname><given-names>DL</given-names></name> (<year>1997</year>) <article-title>Overview of dietary sodium effects on and interactions with cardiovascular and neuroendocrine functions</article-title>. <source>Am J Clin Nutr</source>
<volume>65</volume>: <fpage>594S</fpage>&#x02013;<lpage>605S</lpage>.
<pub-id pub-id-type="pmid">9022554</pub-id></mixed-citation></ref><ref id="pone.0142689.ref048"><label>48</label><mixed-citation publication-type="journal">
<name><surname>Blackburn</surname><given-names>EH</given-names></name>, <name><surname>Collins</surname><given-names>K</given-names></name> (<year>2011</year>) <article-title>Telomerase: an RNP enzyme synthesizes DNA</article-title>. <source>Cold Spring Harb Perspect Biol</source>
<volume>3</volume>.</mixed-citation></ref><ref id="pone.0142689.ref049"><label>49</label><mixed-citation publication-type="journal">
<name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Kha</surname><given-names>H</given-names></name>, <name><surname>Ungrin</surname><given-names>M</given-names></name>, <name><surname>Robinson</surname><given-names>MO</given-names></name>, <name><surname>Harrington</surname><given-names>L</given-names></name> (<year>2002</year>) <article-title>Preferential maintenance of critically short telomeres in mammalian cells heterozygous for mTert</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>99</volume>: <fpage>3597</fpage>&#x02013;<lpage>3602</lpage>.
<pub-id pub-id-type="pmid">11904422</pub-id></mixed-citation></ref><ref id="pone.0142689.ref050"><label>50</label><mixed-citation publication-type="journal">
<name><surname>Ouellette</surname><given-names>MM</given-names></name>, <name><surname>McDaniel</surname><given-names>LD</given-names></name>, <name><surname>Wright</surname><given-names>WE</given-names></name>, <name><surname>Shay</surname><given-names>JW</given-names></name>, <name><surname>Schultz</surname><given-names>RA</given-names></name> (<year>2000</year>) <article-title>The establishment of telomerase-immortalized cell lines representing human chromosome instability syndromes</article-title>. <source>Hum Mol Genet</source>
<volume>9</volume>: <fpage>403</fpage>&#x02013;<lpage>411</lpage>.
<pub-id pub-id-type="pmid">10655550</pub-id></mixed-citation></ref><ref id="pone.0142689.ref051"><label>51</label><mixed-citation publication-type="journal">
<name><surname>Gorbunova</surname><given-names>V</given-names></name>, <name><surname>Seluanov</surname><given-names>A</given-names></name>, <name><surname>Pereira-Smith</surname><given-names>OM</given-names></name> (<year>2002</year>) <article-title>Expression of human telomerase (hTERT) does not prevent stress-induced senescence in normal human fibroblasts but protects the cells from stress-induced apoptosis and necrosis</article-title>. <source>J Biol Chem</source>
<volume>277</volume>: <fpage>38540</fpage>&#x02013;<lpage>38549</lpage>.
<pub-id pub-id-type="pmid">12140282</pub-id></mixed-citation></ref><ref id="pone.0142689.ref052"><label>52</label><mixed-citation publication-type="journal">
<name><surname>Epel</surname><given-names>ES</given-names></name>, <name><surname>Blackburn</surname><given-names>EH</given-names></name>, <name><surname>Lin</surname><given-names>J</given-names></name>, <name><surname>Dhabhar</surname><given-names>FS</given-names></name>, <name><surname>Adler</surname><given-names>NE</given-names></name>, <name><surname>Morrow</surname><given-names>JD</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Accelerated telomere shortening in response to life stress</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>101</volume>: <fpage>17312</fpage>&#x02013;<lpage>17315</lpage>.
<pub-id pub-id-type="pmid">15574496</pub-id></mixed-citation></ref><ref id="pone.0142689.ref053"><label>53</label><mixed-citation publication-type="journal">
<name><surname>Nazari-Shafti</surname><given-names>T</given-names></name>, <name><surname>Cooke</surname><given-names>J</given-names></name> (<year>2015</year>) <article-title>Telomerase therapy to reverse cardiovascular senescence</article-title>. <source>Methodist Debakey Cardiovasc J</source>
<volume>11</volume>: <fpage>172</fpage>&#x02013;<lpage>175</lpage>.<pub-id pub-id-type="pmid">26634025</pub-id></mixed-citation></ref><ref id="pone.0142689.ref054"><label>54</label><mixed-citation publication-type="journal">
<name><surname>Jeanclos</surname><given-names>E</given-names></name>, <name><surname>Schork</surname><given-names>NJ</given-names></name>, <name><surname>Kyvik</surname><given-names>KO</given-names></name>, <name><surname>Kimura</surname><given-names>M</given-names></name>, <name><surname>Skurnick</surname><given-names>JH</given-names></name>, <name><surname>Aviv</surname><given-names>A</given-names></name> (<year>2000</year>) <article-title>Telomere length inversely correlates with pulse pressure and is highly familial</article-title>. <source>Hypertension</source>
<volume>36</volume>: <fpage>195</fpage>&#x02013;<lpage>200</lpage>.
<pub-id pub-id-type="pmid">10948077</pub-id></mixed-citation></ref><ref id="pone.0142689.ref055"><label>55</label><mixed-citation publication-type="journal">
<name><surname>Bhupatiraju</surname><given-names>C</given-names></name>, <name><surname>Saini</surname><given-names>D</given-names></name>, <name><surname>Patkar</surname><given-names>S</given-names></name>, <name><surname>Deepak</surname><given-names>P</given-names></name>, <name><surname>Das</surname><given-names>B</given-names></name>, <name><surname>Padma</surname><given-names>T</given-names></name> (<year>2012</year>) <article-title>Association of shorter telomere length with essential hypertension in Indian population</article-title>. <source>Am J Hum Biol</source>
<volume>24</volume>: <fpage>573</fpage>&#x02013;<lpage>578</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/ajhb.22264">10.1002/ajhb.22264</ext-link></comment>
<pub-id pub-id-type="pmid">22431479</pub-id></mixed-citation></ref><ref id="pone.0142689.ref056"><label>56</label><mixed-citation publication-type="journal">
<name><surname>Benetos</surname><given-names>A</given-names></name>, <name><surname>Gardner</surname><given-names>JP</given-names></name>, <name><surname>Zureik</surname><given-names>M</given-names></name>, <name><surname>Labat</surname><given-names>C</given-names></name>, <name><surname>Xiaobin</surname><given-names>L</given-names></name>, <name><surname>Adamopoulos</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects</article-title>. <source>Hypertension</source>
<volume>43</volume>: <fpage>182</fpage>&#x02013;<lpage>185</lpage>.
<pub-id pub-id-type="pmid">14732735</pub-id></mixed-citation></ref><ref id="pone.0142689.ref057"><label>57</label><mixed-citation publication-type="journal">
<name><surname>Shalev</surname><given-names>I</given-names></name>, <name><surname>Entringer</surname><given-names>S</given-names></name>, <name><surname>Wadhwa</surname><given-names>PD</given-names></name>, <name><surname>Wolkowitz</surname><given-names>OM</given-names></name>, <name><surname>Puterman</surname><given-names>E</given-names></name>, <name><surname>Lin</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Stress and telomere biology: a lifespan perspective</article-title>. <source>Psychoneuroendocrinology</source>
<volume>38</volume>: <fpage>1835</fpage>&#x02013;<lpage>1842</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.psyneuen.2013.03.010">10.1016/j.psyneuen.2013.03.010</ext-link></comment>
<pub-id pub-id-type="pmid">23639252</pub-id></mixed-citation></ref><ref id="pone.0142689.ref058"><label>58</label><mixed-citation publication-type="journal">
<name><surname>Puterman</surname><given-names>E</given-names></name>, <name><surname>Epel</surname><given-names>E</given-names></name> (<year>2012</year>) <article-title>An intricate dance: Life experience, multisystem resiliency, and rate of telomere decline throughout the lifespan</article-title>. <source>Soc Personal Psychol Compass</source>
<volume>6</volume>: <fpage>807</fpage>&#x02013;<lpage>825</lpage>.
<pub-id pub-id-type="pmid">23162608</pub-id></mixed-citation></ref><ref id="pone.0142689.ref059"><label>59</label><mixed-citation publication-type="journal">
<name><surname>Lavretsky</surname><given-names>H</given-names></name>, <name><surname>Epel</surname><given-names>ES</given-names></name>, <name><surname>Siddarth</surname><given-names>P</given-names></name>, <name><surname>Nazarian</surname><given-names>N</given-names></name>, <name><surname>Cyr</surname><given-names>NS</given-names></name>, <name><surname>Khalsa</surname><given-names>DS</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>A pilot study of yogic meditation for family dementia caregivers with depressive symptoms: effects on mental health, cognition, and telomerase activity</article-title>. <source>Int J Geriatr Psychiatry</source>
<volume>28</volume>: <fpage>57</fpage>&#x02013;<lpage>65</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/gps.3790">10.1002/gps.3790</ext-link></comment>
<pub-id pub-id-type="pmid">22407663</pub-id></mixed-citation></ref><ref id="pone.0142689.ref060"><label>60</label><mixed-citation publication-type="journal">
<name><surname>Jacobs</surname><given-names>TL</given-names></name>, <name><surname>Epel</surname><given-names>ES</given-names></name>, <name><surname>Lin</surname><given-names>J</given-names></name>, <name><surname>Blackburn</surname><given-names>EH</given-names></name>, <name><surname>Wolkowitz</surname><given-names>OM</given-names></name>, <name><surname>Bridwell</surname><given-names>DA</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Intensive meditation training, immune cell telomerase activity, and psychological mediators</article-title>. <source>Psychoneuroendocrinology</source>
<volume>36</volume>: <fpage>664</fpage>&#x02013;<lpage>681</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.psyneuen.2010.09.010">10.1016/j.psyneuen.2010.09.010</ext-link></comment>
<pub-id pub-id-type="pmid">21035949</pub-id></mixed-citation></ref><ref id="pone.0142689.ref061"><label>61</label><mixed-citation publication-type="journal">
<name><surname>Dusek</surname><given-names>JA</given-names></name>, <name><surname>Otu</surname><given-names>HH</given-names></name>, <name><surname>Wohlhueter</surname><given-names>AL</given-names></name>, <name><surname>Bhasin</surname><given-names>M</given-names></name>, <name><surname>Zerbini</surname><given-names>LF</given-names></name>, <name><surname>Joseph</surname><given-names>MG</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Genomic counter-stress changes induced by the relaxation response</article-title>. <source>PLoS ONE</source>
<volume>3</volume>: <fpage>e2576</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0002576">10.1371/journal.pone.0002576</ext-link></comment>
<pub-id pub-id-type="pmid">18596974</pub-id></mixed-citation></ref><ref id="pone.0142689.ref062"><label>62</label><mixed-citation publication-type="journal">
<name><surname>Hamer</surname><given-names>M</given-names></name> (<year>2010</year>) <article-title>Adherence to healthy lifestyle in hypertensive patients: ample room for improvement?</article-title>
<source>J Hum Hypertens</source>
<volume>24</volume>: <fpage>559</fpage>&#x02013;<lpage>560</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/jhh.2010.61">10.1038/jhh.2010.61</ext-link></comment>
<pub-id pub-id-type="pmid">20535139</pub-id></mixed-citation></ref><ref id="pone.0142689.ref063"><label>63</label><mixed-citation publication-type="journal">
<name><surname>Mellen</surname><given-names>PB</given-names></name>, <name><surname>Gao</surname><given-names>SK</given-names></name>, <name><surname>Vitolins</surname><given-names>MZ</given-names></name>, <name><surname>Goff</surname><given-names>DC</given-names><suffix>Jr</suffix></name> (<year>2008</year>) <article-title>Deteriorating dietary habits among adults with hypertension: DASH dietary accordance, NHANES 1988&#x02013;1994 and 1999&#x02013;2004</article-title>. <source>Arch Intern Med</source>
<volume>168</volume>: <fpage>308</fpage>&#x02013;<lpage>314</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/archinternmed.2007.119">10.1001/archinternmed.2007.119</ext-link></comment>
<pub-id pub-id-type="pmid">18268173</pub-id></mixed-citation></ref><ref id="pone.0142689.ref064"><label>64</label><mixed-citation publication-type="journal">
<name><surname>Scheltens</surname><given-names>T</given-names></name>, <name><surname>Beulens</surname><given-names>JW</given-names></name>, <name><surname>Verschuren</surname><given-names>WM</given-names></name>, <name><surname>Boer</surname><given-names>JM</given-names></name>, <name><surname>Hoes</surname><given-names>AW</given-names></name>, <name><surname>Grobbee</surname><given-names>DE</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Awareness of hypertension: will it bring about a healthy lifestyle?</article-title>
<source>J Hum Hypertens</source>
<volume>24</volume>: <fpage>561</fpage>&#x02013;<lpage>567</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/jhh.2010.26">10.1038/jhh.2010.26</ext-link></comment>
<pub-id pub-id-type="pmid">20393503</pub-id></mixed-citation></ref><ref id="pone.0142689.ref065"><label>65</label><mixed-citation publication-type="journal">
<name><surname>Schneider</surname><given-names>R</given-names></name>, <name><surname>Grim</surname><given-names>C</given-names></name>, <name><surname>Rainforth</surname><given-names>M</given-names></name>, <name><surname>Kotchen</surname><given-names>T</given-names></name>, <name><surname>Nidich</surname><given-names>S</given-names></name>, <name><surname>Gaylord-King</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Stress reduction in the secondary prevention of cardiovascular disease: randomized controlled trial of Transcendental Meditation and health education in Blacks</article-title>. <source>Circulation: Cardiovascular Quality and Outcomes</source>
<volume>5</volume>: <fpage>750</fpage>&#x02013;<lpage>758</lpage>.<pub-id pub-id-type="pmid">23149426</pub-id></mixed-citation></ref><ref id="pone.0142689.ref066"><label>66</label><mixed-citation publication-type="journal">
<name><surname>Hedayati</surname><given-names>SS</given-names></name>, <name><surname>Elsayed</surname><given-names>EF</given-names></name>, <name><surname>Reilly</surname><given-names>RF</given-names></name> (<year>2011</year>) <article-title>Non-pharmacological aspects of blood pressure management: what are the data?</article-title>
<source>Kidney Int</source>
<volume>79</volume>: <fpage>1061</fpage>&#x02013;<lpage>1070</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ki.2011.46">10.1038/ki.2011.46</ext-link></comment>
<pub-id pub-id-type="pmid">21389976</pub-id></mixed-citation></ref><ref id="pone.0142689.ref067"><label>67</label><mixed-citation publication-type="journal">
<name><surname>Rothwell</surname><given-names>PM</given-names></name> (<year>2006</year>) <article-title>Factors that can affect the external validity of randomised controlled trials</article-title>. <source>PLoS Clin Trials</source>
<volume>1</volume>: <fpage>e9</fpage>
<pub-id pub-id-type="pmid">16871331</pub-id></mixed-citation></ref><ref id="pone.0142689.ref068"><label>68</label><mixed-citation publication-type="journal">
<name><surname>Ehrlenbach</surname><given-names>S</given-names></name>, <name><surname>Willeit</surname><given-names>P</given-names></name>, <name><surname>Kiechl</surname><given-names>S</given-names></name>, <name><surname>Willeit</surname><given-names>J</given-names></name>, <name><surname>Reindl</surname><given-names>M</given-names></name>, <name><surname>Schanda</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Influences on the reduction of relative telomere length over 10 years in the population-based Bruneck Study: introduction of a well-controlled high-throughput assay</article-title>. <source>Int J Epidemiol</source>
<volume>38</volume>: <fpage>1725</fpage>&#x02013;<lpage>1734</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/ije/dyp273">10.1093/ije/dyp273</ext-link></comment>
<pub-id pub-id-type="pmid">19666704</pub-id></mixed-citation></ref><ref id="pone.0142689.ref069"><label>69</label><mixed-citation publication-type="journal">
<name><surname>Orme-Johnson</surname><given-names>D</given-names></name>, <name><surname>Barnes</surname><given-names>V</given-names></name> (<year>2013</year>) <article-title>Effects of the Transcendental Meditation technique on Trait Anxiety: A Meta-Analysis of Randomized Controlled Trials</article-title>. <source>Journal of Alternative and Complementary Medicine</source>
<volume>19</volume>: <fpage>1</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">22954464</pub-id></mixed-citation></ref><ref id="pone.0142689.ref070"><label>70</label><mixed-citation publication-type="journal">
<name><surname>Sedlmeier</surname><given-names>P</given-names></name>, <name><surname>Eberth</surname><given-names>J</given-names></name>, <name><surname>Schwarz</surname><given-names>M</given-names></name>, <name><surname>Zimmermann</surname><given-names>D</given-names></name>, <name><surname>Haarig</surname><given-names>F</given-names></name>, <name><surname>Jaeger</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>The Psychological Effects of Meditation: A Meta-Analysis</article-title>. <source>Psychol Bull</source>: <fpage>1</fpage>&#x02013;<lpage>33</lpage>.</mixed-citation></ref><ref id="pone.0142689.ref071"><label>71</label><mixed-citation publication-type="journal">
<name><surname>Son</surname><given-names>NH</given-names></name>, <name><surname>Joyce</surname><given-names>B</given-names></name>, <name><surname>Hieatt</surname><given-names>A</given-names></name>, <name><surname>Chrest</surname><given-names>FJ</given-names></name>, <name><surname>Yanovski</surname><given-names>J</given-names></name>, <name><surname>Weng</surname><given-names>NP</given-names></name> (<year>2003</year>) <article-title>Stable telomere length and telomerase expression from naive to memory B-lymphocyte differentiation</article-title>. <source>Mech Ageing Dev</source>
<volume>124</volume>: <fpage>427</fpage>&#x02013;<lpage>432</lpage>.
<pub-id pub-id-type="pmid">12714249</pub-id></mixed-citation></ref><ref id="pone.0142689.ref072"><label>72</label><mixed-citation publication-type="journal">
<name><surname>Buchkovich</surname><given-names>K</given-names></name>, <name><surname>Greider</surname><given-names>C</given-names></name> (<year>1996</year>) <article-title>Telomerase regulation during entry into the cellcycle in normal human T cells</article-title>. <source>Mol Biol Cell</source>
<volume>7</volume>: <fpage>1443</fpage>&#x02013;<lpage>1454</lpage>.
<pub-id pub-id-type="pmid">8885238</pub-id></mixed-citation></ref><ref id="pone.0142689.ref073"><label>73</label><mixed-citation publication-type="journal">
<name><surname>Harris</surname><given-names>AD</given-names></name>, <name><surname>McGregor</surname><given-names>JC</given-names></name>, <name><surname>Perencevich</surname><given-names>EN</given-names></name>, <name><surname>Furuno</surname><given-names>JP</given-names></name>, <name><surname>Zhu</surname><given-names>J</given-names></name>, <name><surname>Peterson</surname><given-names>DE</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>The use and interpretation of quasi-experimental studies in medical informatics</article-title>. <source>J Am Med Inform Assoc</source>
<volume>13</volume>: <fpage>16</fpage>&#x02013;<lpage>23</lpage>.
<pub-id pub-id-type="pmid">16221933</pub-id></mixed-citation></ref></ref-list></back></article>